Document:

Exhibit 4.2

 

THIRD
SUPPLEMENTAL INDENTURE 

 

between 

 

BUSINESS DEVELOPMENT CORPORATION OF AMERICA

 

and 

 

U.S. BANK NATIONAL ASSOCIATION, 

 

as Trustee 

 

Dated as of December 5, 2019 

 

 

THIRD SUPPLEMENTAL INDENTURE

 

THIS THIRD SUPPLEMENTAL INDENTURE (this
“Third Supplemental Indenture”), dated as of December 5, 2019, is between Business Development Corporation of America,
a Maryland corporation (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).
All capitalized terms used herein shall have the meaning set forth in the Base Indenture (as defined below).

 

RECITALS OF THE COMPANY 

 

The Company and the Trustee executed and
delivered an Indenture, dated as of December 19, 2017 (the “Base Indenture” and, as supplemented by this Third Supplemental
Indenture, the “Indenture”), to provide for the issuance by the Company from time to time of the Company’s debt
securities (the “Securities”), to be issued in one or more series as provided in the Base Indenture.

 

The Company desires to issue and sell its
4.85% Notes due 2024 (the “Notes”).

 

Sections 901(4) and 901(6) of the Base
Indenture provide that without the consent of Holders of the Securities of any series issued under the Indenture, the Company,
when authorized by or pursuant to a Board Resolution, and the Trustee, at any time and from time to time, may enter into one or
more indentures supplemental to the Base Indenture to (i) change or eliminate any of the provisions of the Indenture when
there is no Security Outstanding of any series created prior to the execution of the supplemental indenture that is entitled to
the benefit of such provision and (ii) establish the form or terms of Securities of any series as permitted by Section 201
and Section 301 of the Base Indenture.

 

The Company desires to establish the form
and terms of the Notes and to modify, alter, supplement and change certain provisions of the Base Indenture for the benefit of
the Holders of the Notes.

 

The Company has duly authorized the execution
and delivery of this Third Supplemental Indenture to provide for the issuance of the Notes and all acts and things necessary to
make this Third Supplemental Indenture a valid, binding, and legal obligation of the Company and to constitute a valid agreement
of the Company, in accordance with its terms, have been done and performed.

 

NOW, THEREFORE, for and in consideration
of the premises and the purchase of the Notes by the Holders thereof, it is mutually agreed, for the equal and proportionate benefit
of all Holders of the Notes, as follows:

 

ARTICLE I 

TERMS OF THE NOTES 

 

Section 1.01 Terms of the Notes.
The following terms relating to the Notes are hereby established:

 

(a) The Notes shall constitute a series
of Senior Securities having the title “4.85% Notes due 2024.” The Notes offered and sold to QIBs in reliance on Rule
144A shall bear a CUSIP number of 12325J AF8 and an ISIN number of US12325JAF84 and the Notes offered and sold to IAIs under Rule
501(a)(1), (2), (3) or (7) under the Securities Act shall bear a CUSIP number of 12325J AG6 and an ISIN number of US12325JAG67.

 

     

     

    

 

(b) The aggregate principal amount of the
Notes that may be initially authenticated and delivered under the Indenture (except for Notes authenticated and delivered upon
registration of, transfer of, or in exchange for, or in lieu of, other Notes pursuant to Sections 304, 305, 306, 906 or 1107 of
the Base Indenture, and except for any Securities that, pursuant to Section 303 of the Base Indenture, are deemed never to
have been authenticated and delivered under the Indenture) shall be unlimited. The Board has authorized the issuance of an initial
amount of $100,000,000 aggregate principal of the Notes. Under a Board Resolution, Officers’ Certificate pursuant to Board
Resolutions or an indenture supplement, the Company may from time to time, without the consent of the Holders of Notes, issue additional
Notes (in any such case “Additional Notes”) having the same ranking and the same interest rate, maturity and other
terms as the Notes. Any Additional Notes and the existing Notes will constitute a single series under the Indenture and all references
to the relevant Notes herein shall include the Additional Notes unless the context otherwise requires.

 

(c) The entire outstanding principal of
the Notes shall be payable on December 15, 2024.

 

(d) The rate at which the Notes shall bear
interest shall be 4.85% per annum (the “Applicable Interest Rate”). The date from which interest shall accrue
on the Notes shall be December 5, 2019, or the most recent Interest Payment Date to which interest has been paid or provided for;
the Interest Payment Dates for the Notes shall be June 15 and December 15 of each year, commencing June 15, 2020 (if an Interest
Payment Date falls on a day that is not a Business Day, then the applicable interest payment will be made on the next succeeding
Business Day and no additional interest will accrue as a result of such delayed payment); the initial interest period will be the
period from and including December 5, 2019, to, but excluding, the initial Interest Payment Date, and the subsequent interest periods
will be the periods from and including an Interest Payment Date to, but excluding, the next Interest Payment Date or the Stated
Maturity, as the case may be; the interest so payable, and punctually paid or duly provided for, on any Interest Payment Date,
will be paid to the Person in whose name the Note (or one or more Predecessor Notes) is registered at the close of business on
the Regular Record Date for such interest, which shall be May 30 or November 30 (whether or not a Business Day), as the case may
be, next preceding such Interest Payment Date. Payment of principal of (and premium, if any, on) and any such interest on the Notes
will be made at the office of the Trustee located at 214 N. Tryon Street, 27th Floor, Charlotte, NC 28202 and at such other address
as designated by the Company, in such coin or currency of the United States of America as at the time of payment is legal tender
for payment of public and private debts; provided, however, that at the option of the Company payment of interest may be
made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register; provided,
further, however, that so long as the Notes are registered to Cede & Co., such payment will be made by wire transfer
in accordance with the procedures established by The Depository Trust Company and the Trustee. Interest on the Notes will be computed
on the basis of a 360-day year of twelve 30-day months.

 

(e) The Notes offered and sold to QIBs
in reliance on Rule 144A shall be initially issuable in global form (each such Note, a “144A Global Note”) which, along
with the Trustee’s certificate of authentication for such 144A Global Note, shall be substantially in the form of Exhibit
A to this Third Supplemental Indenture. The Notes offered and sold to IAIs under Rule 501(a)(1), (2), (3) or (7) under the Securities
Act shall be initially issuable in global form (each such Note, a “IAI Global Note,” together with each 144A Global
Notes, the “Global Notes”) which, along with the Trustee’s certificate of authentication for such IAI Global
Note, shall be substantially in the form of Exhibit B to this Third Supplemental Indenture. Each Global Note shall represent the
outstanding Notes as shall be specified therein and each shall provide that it shall represent the aggregate amount of outstanding
Notes from time to time endorsed thereon and that the aggregate amount of outstanding Notes represented thereby may from time to
time be reduced or increased, as appropriate, to reflect exchanges and redemptions. Any endorsement of a Global Note to reflect
the amount of any increase or decrease in the amount of outstanding Notes represented thereby shall be made by the Trustee or the
Security Registrar, in accordance with Sections 203 and 305 of the Base Indenture.

 

(f) The depository for such Global Notes
(the “Depository”) shall be The Depository Trust Company, New York, New York. The Security Registrar with respect to
the Global Notes shall be the Trustee.

 

     

     

    

 

(g) The Notes shall be defeasible pursuant
to Section 1302 or Section 1303 of the Base Indenture. Covenant defeasance contained in Section 1303 of the Base
Indenture shall apply to the covenants contained in Sections 1005, 1006, and 1007 of the Indenture.

 

(h) The Notes shall be redeemable pursuant
to Section 1101 of the Base Indenture and as follows:

 

(i) Prior to November 15, 2024,
Notes will be redeemable in whole or in part at any time or from time to time, at the option of the Company at the greater of (1)
100% of the principal amount of such Notes to be redeemed plus accrued and unpaid interest to but excluding the Redemption Date,
or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid
interest to but excluding the Redemption Date) on the Notes to be redeemed, discounted to the Redemption Date on a semi-annual
basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable Treasury Rate plus 50 basis points.

 

(ii) On or after November 15,
2024, the Notes will be redeemable in whole or in part at any time or from time to time, at the option of the Company at a redemption
price equal 100% of the outstanding principal amount of the Notes to be redeemed plus accrued and unpaid interest to, but excluding
the Redemption Date.

 

(iii) Notice of redemption shall
be given in writing and mailed, first-class postage prepaid or by overnight courier guaranteeing next-day delivery, to each Holder
of the Notes to be redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date, at
the Holder’s address appearing in the Security Register. All notices of redemption shall contain the information set forth
in Section 1104 of the Base Indenture.

 

(iv) Any exercise of the Company’s
option to redeem the Notes will be done in compliance with the Investment Company Act, to the extent applicable.

 

(v) If the Company elects to
redeem only a portion of the Notes, the Trustee will determine the method for selecting the particular Notes to be redeemed, in
accordance with the Investment Company Act, to the extent applicable.

 

(vi) Unless the Company defaults
in payment of the Redemption Price, on and after the Redemption Date, interest will cease to accrue on the Notes called for redemption
hereunder.

 

(i) The Notes shall not be subject to any
sinking fund.

 

(j) Holders of the Notes will not have
the option to have the Notes repaid prior to the Stated Maturity.

 

(k) The Notes are hereby designated as
“Senior Securities” under the Indenture.

 

ARTICLE II 

MISCELLANEOUS 

 

Section 201 This Third Supplemental
Indenture and the Notes shall be governed by and construed in accordance with the law of the State of New York. This Third Supplemental
Indenture is subject to the provisions of the Trust Indenture Act that are required to be part of the Indenture and shall, to the
extent applicable, be governed by such provisions.

 

Section 202 In case any provision
in this Third Supplemental Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby.

 

Section 203 This Third Supplemental
Indenture may be executed in counterparts, each of which will be an original, but such counterparts will together constitute but
one and the same Third Supplemental Indenture. The exchange of copies of this Third Supplemental Indenture and of signature pages
by facsimile, .pdf transmission, email or other electronic means shall constitute effective execution and delivery of this Third
Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile, .pdf transmission, email or
other electronic means shall be deemed to be their original signatures for all purposes.

 

     

     

    

 

Section 204 The Base Indenture,
as supplemented and amended by this Third Supplemental Indenture, is in all respects ratified and confirmed, and the Base Indenture
and this Third Supplemental Indenture shall be read, taken and construed as one and the same instrument with respect to the Notes.
All provisions included in this Third Supplemental Indenture supersede any conflicting provisions included in the Base Indenture
with respect to the Notes, unless not permitted by law. The Trustee accepts the trusts created by the Base Indenture, as supplemented
by this Third Supplemental Indenture, and agrees to perform the same upon the terms and conditions of the Base Indenture, as supplemented
by this Third Supplemental Indenture.

 

Section 205 The provisions of this
Third Supplemental Indenture shall become effective as of the date hereof.

 

Section 206 Notwithstanding anything
else to the contrary herein, the terms and provisions of this Third Supplemental Indenture, and any modifications to the Base Indenture
provided herein, shall apply only to the Notes and shall not apply to any other series of Securities under the Indenture and this
Third Supplemental Indenture shall not and does not otherwise affect, modify, alter, supplement or change the terms and provisions
of any other series of Securities under the Indenture, whether now or hereafter issued and Outstanding.

 

Section 207 The recitals contained
herein and in the Notes shall be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness.
The Trustee makes no representations as to the validity or sufficiency of this Third Supplemental Indenture, the Notes or any Additional
Notes, except that the Trustee represents that it is duly authorized to execute and deliver this Third Supplemental Indenture,
authenticate the Notes and any Additional Notes and perform its obligations hereunder. The Trustee shall not be accountable for
the use or application by the Company of the Notes or any Additional Notes or the proceeds thereof.

 

IN WITNESS WHEREOF, the parties hereto
have caused this Third Supplemental Indenture to be duly executed as of the date first above written.

 

	 	BUSINESS DEVELOPMENT CORPORATION OF AMERICA
	 	 	 
	 	By:	 /s/
Richard J. Byrne 

	 	Name:	Richard J. Byrne
	 	Title:	Chief Executive Officer
	 	 
	 	U.S. BANK NATIONAL ASSOCIATION, as Trustee
	 	 	 
	 	By:	/s/
Allison Lancaster-Poole

	 	Name:	Allison Lancaster-Poole
	 	Title:	Vice President

 

[Signature page to Third Supplemental
Indenture]

 

     

     

    

 

Exhibit A – Form of 144A Global
Note 

 

BUSINESS DEVELOPMENT CORPORATION OF
AMERICA

 

4.85% Notes due 2024

 

UNLESS THIS CERTIFICATE IS PRESENTED BY
AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW
YORK, TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN
THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE
TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER
USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS
AN INTEREST HEREIN.

 

TRANSFERS OF THIS GLOBAL SECURITY SHALL
BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S
NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS
SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF.

 

THIS SECURITY HAS NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS. NEITHER THIS SECURITY
NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED
OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT.

 

THE HOLDER OF THIS SECURITY BY ITS ACCEPTANCE
HEREOF (1) REPRESENTS THAT IT IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT
(“RULE 144A”)) AND (2) AGREES TO OFFER, SELL OR OTHERWISE TRANSFER SUCH SECURITY, PRIOR TO THE DATE (THE “RESALE
RESTRICTION TERMINATION DATE”) WHICH IS SIX MONTHS (OR SUCH OTHER DATE WHEN RESALES OF SECURITIES BY NON-AFFILIATES ARE
FIRST PERMITTED UNDER RULE 144(d)) AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF (OR ANY PREDECESSOR OF THIS SECURITY) OR THE
DATE OF ANY SUBSEQUENT REOPENING OF THE SECURITIES AND THE LAST DATE ON WHICH THE COMPANY OR ANY AFFILIATE OF THE COMPANY WAS THE
OWNER OF THIS SECURITY (OR ANY PREDECESSOR OF SUCH SECURITY), ONLY (A) TO THE COMPANY OR ANY OF ITS SUBSIDIARIES, (B) PURSUANT
TO A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT, (C) FOR SO LONG AS THE SECURITIES ARE ELIGIBLE
FOR RESALE PURSUANT TO RULE 144A, TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED
IN RULE 144A) THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN
THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (D) TO AN INSTITUTIONAL “ACCREDITED INVESTOR” WITHIN THE
MEANING OF RULE 501(a)(1), (2), (3) OR (7) UNDER THE SECURITIES ACT THAT IS NOT A QUALIFIED INSTITUTIONAL BUYER AND THAT IS PURCHASING
FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF ANOTHER INSTITUTIONAL ACCREDITED INVESTOR OR (E) PURSUANT TO ANOTHER AVAILABLE EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND THE SECURITIES LAWS OF ANY OTHER JURISDICTION, INCLUDING ANY STATE
OF THE UNITED STATES, SUBJECT TO THE COMPANY’S AND THE TRUSTEE’S RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER TO
REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL SATISFACTORY TO EACH OF THEM AND/OR A CERTIFICATE OF TRANSFER OR EXCHANGE IN THE
FORM PRESCRIBED IN THE INDENTURE. THIS LEGEND WILL BE REMOVED UPON THE REQUEST OF THE HOLDER AFTER THE RESALE RESTRICTION TERMINATION
DATE.

 

     

     

    

 

BY ITS ACQUISITION AND HOLDING OF THIS
SECURITY, THE HOLDER THEREOF WILL BE DEEMED TO HAVE REPRESENTED, WARRANTED AND AGREED THAT EITHER (I) IT IS NOT AND WILL NOT BE
FOR SO LONG AS IT HOLDS ANY SECURITY (OR INTEREST IN A SECURITY) AN EMPLOYEE BENEFIT PLAN OR ARRANGEMENT SUBJECT TO THE FIDUCIARY
RESPONSIBILITY REQUIREMENT OF TITLE I OF U.S. EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”),
A “PLAN” OR ARRANGEMENT SUBJECT TO SECTION 4975 OF THE U.S. INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”),
OR AN ENTITY WHOSE UNDERLYING ASSETS INCLUDE PLAN ASSETS BY REASON OF SUCH EMPLOYEE BENEFIT PLAN OR PLAN’S INVESTMENT IN
THE ENTITY, OR A GOVERNMENTAL, NON-U.S., CHURCH OR OTHER PLAN WHICH IS SUBJECT TO ANY FEDERAL, STATE, LOCAL, NON-U.S. OR OTHER
LAWS OR REGULATIONS THAT ARE SUBSTANTIALLY SIMILAR TO SUCH PROVISIONS OF ERISA OR THE CODE (“SIMILAR LAWS”),
OR (II) THE PURCHASE, HOLDING AND DISPOSITION OF THIS SECURITY WILL NOT CONSTITUTE A NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION
406 OF ERISA OR SECTION 4975 OF THE CODE OR, IN THE CASE OF A GOVERNMENTAL, NON-U.S., CHURCH OR OTHER PLAN, A SIMILAR VIOLATION
UNDER ANY APPLICABLE SIMILAR LAWS.

 

Business Development Corporation of
America

 

	No. [_____]	Principal Amount $[•]
	ISIN No. US12325JAF84	CUSIP No. 12325J AF8

 

4.85% Notes due 2024

 

Business Development
Corporation of America, a corporation duly organized and existing under the laws of Maryland (herein called the “Company”,
which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay
to Cede & Co., or registered assigns, the principal sum of [•] (U.S. $[•]), as revised by the Schedule of Increases
and Decreases in Global Security attached hereto, on December 15, 2024.

 

Interest Payment Dates: June 15 and December
15, commencing on June 15, 2020

 

Record Dates: May 30 and November 30

 

Additional provisions of this Security
are set forth on the other side of this Security.

 

     

     

    

 

IN WITNESS WHEREOF,
the Company has caused this Security to be duly executed.

 

	Dated:	December 5, 2019
	 	 

	 	BUSINESS DEVELOPMENT CORPORATION OF AMERICA
	 	 

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

 

	
        Attest:
	 
	 
	Name:	 	 
	Title:	 	 

 

     

     

    

 

TRUSTEE CERTIFICATE OF AUTHENTICATION

 

This Security is one of the Securities
of the series referred to in the within-mentioned Indenture.

 

	Dated:  	December 5, 2019

 

	 	
        U.S. BANK NATIONAL ASSOCIATION,

         

        as Trustee

	 	 
	 	 
	 	
        By:
	 

	 	 	Authorized Signatory

 

     

     

    

 

[FORM OF REVERSE SIDE OF SECURITY]

 

Business Development Corporation of America

 

4.85% Notes due 2024

 

Capitalized terms used
herein and not defined herein have the meanings ascribed thereto in the Indenture.

 

		1.	Interest

 

Business Development
Corporation of America, a Maryland corporation, promises to pay interest on the principal amount of this Security at 4.85% per
annum from December 5, 2019 until maturity. The Company will pay interest semi-annually in arrears every June 15 and December 15
of each year, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment
Date”). Interest on the Securities of this series shall accrue from the most recent date to which interest has been paid
or if no interest has been paid, from the date of issuance; provided, that the first Interest Payment Date shall be June 15, 2020.
The Company shall pay interest on overdue principal at the rate specified herein, and it shall pay interest (including post-petition
interest in any proceeding under any Bankruptcy Law) on overdue installments of interest (without regard to any applicable grace
period) at the same rate to the extent lawful. Interest on the Securities will be computed on the basis of a 360-day year comprised
of twelve 30-day months.

 

		2.	Method of Payment

 

Payment of interest
on any Security which is payable, and is timely paid or duly provided for, on any Interest Payment Date shall be made at the Corporate
Trust Office of the Trustee in such Currency of the United States of America as at the time of payment is legal tender for payment
of public and private debts. At the option of the Company, all payments of interest may be paid by check to the registered Holder
of the Registered Security or other person entitled thereto against surrender of such Security.

 

Payments of principal
of (and premium, if any, on) and interest, if any, on Securities represented by Global Securities that are registered in the name
of or held by DTC or its nominee shall be made by wire transfer of immediately available funds to the accounts specified by DTC
or its nominee, as the case may be, as the Holder of such Global Securities.

 

No reference herein
to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which
is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate,
and in the coin or currency, herein prescribed.

 

		3.	Paying Agent and Registrar

 

The Company initially
appoints U.S. Bank National Association (the “Trustee”) as Registrar and Paying Agent for the Securities. The
Company may change any Registrar or Paying Agent without prior notice to the Holders. The Company may act as Paying Agent, Registrar
or transfer agent.

 

		4.	Indenture

 

The Company issued
the Securities under an Indenture dated as of December 19, 2017 between us and U.S. Bank, as trustee, as supplemented by the third
supplemental indenture between us and U.S. Bank, as trustee, dated as of December 5, 2019 (as it may be further amended or supplemented
from time to time with respect to the Securities in accordance with the terms thereof, the “Indenture”), among
the Company and the Trustee. This Security is one of the series designated on the face hereof. The terms of the Securities include
those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections
77aaa-77bbbb) as in effect on the date of the Indenture (the “Act”). The Securities are subject to all terms
and provisions of the Indenture, and Holders are referred to the Indenture and the Act for a statement of those terms.

 

     

     

    

 

		5.	Redemption

 

The Securities of this
series are subject to redemption in whole or in part at any time or from time to time, at the option of the Company, at a redemption
price per Security equal to the greater of the following amounts, plus, in each case, accrued and unpaid interest to but excluding
the Redemption Date:

 

		a.	100% of the principal amount of such Securities to be redeemed plus accrued and unpaid interest
to but excluding the Redemption Date; and

 

		b.	the sum of the present values of the remaining scheduled payments of principal and interest (exclusive
of accrued and unpaid interest to but excluding the Redemption Date) on the Securities to be redeemed, discounted to the Redemption
Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable Treasury Rate plus
50 basis points.

 

All determinations
with respect to the Redemption Price made by any Reference Treasury Dealer, including the Quotation Agent, shall be final and binding
absent manifest error.

 

Notice of redemption
shall be given in writing and mailed, first-class postage prepaid or by overnight courier guaranteeing next-day delivery, to each
Holder of the Securities to be redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date,
at the Holder’s address appearing in the Security Register. All notices of redemption shall contain the information set forth
in Section 1104 of the Indenture.

 

Any exercise of the
Company’s option to redeem the Securities will be done in compliance with the Investment Company Act of 1940, as amended,
to the extent applicable.

 

If less than all the
Securities of this series issued on the same day with the same terms are to be redeemed, the particular Securities to be redeemed
shall be selected not more than 60 days prior to the Redemption Date by the Trustee in compliance with the requirements of DTC,
from the Outstanding Securities of this series issued on such date with the same terms not previously called for redemption, in
compliance with the requirements of the principal national securities exchange on which the Securities are listed (if the Securities
are listed on any national securities exchange), or if the Securities are not held through DTC or listed on any national securities
exchange, or DTC prescribed no method of selection, on a pro rata basis, or by such method as the Trustee shall deem fair and appropriate
and subject to and otherwise in accordance with the procedures of the applicable Depository; provided that such method complies
with the rules of any national securities exchange or quotation system on which the Securities are listed, and may provide for
the selection for redemption of portions (equal to the minimum authorized denomination for such Securities or any integral multiple
thereof) of the principal amount of Securities of a denomination larger than the minimum authorized denomination for Securities;
provided, however that no such partial redemption shall reduce the portion of the principal amount of a Security not redeemed to
less than $1,000.

 

Unless the Company
defaults in payment of the Redemption Price, on and after the Redemption Date, interest will cease to accrue on the Securities
called for redemption.

 

Notwithstanding the
foregoing, at any time on or after November 15, 2024, the Company may redeem some or all of the Notes at any time, or from time
to time, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed plus accrued and unpaid interest
to, but excluding, the redemption date.

 

		6.	Repurchase Provisions

 

Holders will have the
right to require the Company to repurchase their Securities upon the occurrence of a Change of Control Repurchase Event as set
forth in the Indenture.

 

     

     

    

 

		7.	Denominations; Transfer; Exchange

 

As provided in the
Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register,
upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal
of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer
in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized
in writing, and thereupon one or more new Securities of this series of like tenor, of authorized denominations and for the same
aggregate principal amount, will be issued to the designated transferee or transferees.

 

The Securities of this
series are issuable only in registered form without coupons in denominations of $1,000 and any integral multiples of $1,000 in
excess thereof. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are
exchangeable for a like aggregate principal amount of Securities of this series and of like tenor, of a different authorized denomination,
as requested by the Holder surrendering the same.

 

No service charge shall
be made for any such registration of transfer or exchange, but the Company or Trustee may require payment of a sum sufficient to
cover any tax or other governmental charge payable in connection therewith.

 

Prior to due presentment
of this Security for registration of transfer the Company, the Trustee and any agent of the Company or the Trustee may treat the
Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.

 

		8.	Persons Deemed Owners

 

The registered Holder
of this Security may be treated as the owner of it for all purposes.

 

		9.	Discharge and Defeasance

 

The Indenture contains
provisions for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of
Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture.

 

		10.	Amendment, Supplement, Waiver

 

Subject to certain
exceptions contained in the Indenture, the Indenture and the Securities of this series may be amended, or a Default thereunder
may be waived, with the consent of the Holders of a majority in aggregate principal amount of the outstanding Securities of this
series. Without notice to or the consent of any Holder, the Company, and the Trustee may amend or supplement the Indenture and
the Securities as provided in the Indenture.

 

		11.	Defaults and Remedies

 

If an Event of Default
(other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization of the Company) with respect
to Securities of this series occurs and is continuing, the Trustee by notice to the Company, or the Holders of at least 25% in
principal amount of the outstanding Securities of this series by notice to the Company and the Trustee, may declare the principal
of, premium, if any, and accrued and unpaid interest, and any other monetary obligations on all the Securities of this series to
be due and payable immediately. Upon the effectiveness of such declaration, such principal, premium, interest and other monetary
obligations will be due and payable immediately. If a bankruptcy, insolvency or reorganization of the Company occurs and is continuing,
the principal of, premium, if any, and accrued and unpaid interest and any other monetary obligations on all the Securities of
this series will become and be immediately due and payable without any declaration or other act on the part of the Trustee or any
Holders. Under certain circumstances, the Holders of a majority in principal amount of the outstanding Securities of this series
may rescind any such acceleration with respect to the Securities of this series and its consequences.

 

     

     

    

 

As provided in and
subject to the provisions of the Indenture, the Holder of this Security shall not have the right to institute any proceeding with
respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder
shall have previously given the Trustee written notice of a continuing Event of Default with respect to the Securities of this
series, the Holders of not less than 25% in principal amount of the Securities of this series at the time Outstanding shall have
made written request to the Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee
indemnity, security, or both, satisfactory to the Trustee, against the costs, expenses and liabilities to be incurred in compliance
with such request, and the Trustee shall not have received from the Holders of a majority in principal amount of Securities of
this series at the time Outstanding a direction inconsistent with such request within sixty (60) days after receipt of such notice,
and the Trustee shall have failed to institute any such proceeding for sixty (60) days after receipt of such notice, request and
offer of indemnity and/or security. The foregoing shall not apply to any suit instituted by the Holder of this Security for the
enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed
herein.

 

		12.	Trustee Dealings with the Company

 

Subject to certain
limitations set forth in the Indenture, the Trustee in its individual or any other capacity may become the owner or pledgee of
Securities and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee.
In addition, the Trustee shall be permitted to engage in transactions with the Company; provided, however, that if the Trustee
acquires any conflicting interest under the TIA, the Trustee must (i) eliminate such conflict within 90 days of acquiring such
conflicting interest or (ii) resign.

 

		13.	No Recourse Against Others

 

No director, manager,
officer, employee, incorporator, shareholder or member of the Company or any of its Subsidiaries or Affiliates, as such, shall
have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect
of, or by reason of such obligations or their creation. Each Holder by accepting a Security waives and releases all such liability.
The waiver and release are part of the consideration for issuance of the Securities. Such waiver may not be effective to waive
liabilities under the U.S. federal securities laws and it is the view of the SEC that such a waiver is against public policy.

 

		14.	Authentication

 

This Security shall
not be valid until an authorized signatory of the Trustee (or an authenticating agent acting on its behalf) manually signs the
certificate of authentication on the other side of this Security.

 

		15.	Abbreviations

 

Customary abbreviations
may be used in the name of a Holder or an assignee, such as TEN COM (= tenants in common), TEN ENT (= tenants by the entirety),
JT TEN (= joint tenants with rights of survivorship and not as tenants in common), CUST (= custodian) and U/G/M/A (= Uniform Gift
to Minors Act).

 

		16.	CUSIP and ISIN Numbers

 

The Company has caused
CUSIP numbers, if applicable, to be printed on the Securities and have directed the Trustee to use CUSIP numbers, if applicable,
in notices of redemption or purchase as a convenience to Holders. No representation is made as to the accuracy of such numbers
either as printed on the Securities or as contained in any notice of redemption or purchase and reliance may be placed only on
the other identification numbers placed thereon.

 

		17.	Governing Law; Conflict; Request for Indenture

 

This Security shall
be governed by, and construed in accordance with, the laws of the State of New York. To the extent any provision of this Security
conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling.

 

     

     

    

 

The Company will furnish
to any Holder upon written request and without charge to the Holder a copy of the Indenture. Requests may be made to:

 

Business Development Corporation of America

 

9 West 57th Street, 49th Floor, Suite 4920

 

New York, New York 10019

 

Attention: Chief Financial Officer

 

Facsimile: (844) 643-0430  

 

     

     

    

 

[ASSIGNMENT FORM]

 

To assign this Security, fill in
the form below:

 

I or we assign and transfer this Security
to:

 

(Print or type assignee’s name, address
and zip code)

 

(Insert assignee’s social security
or U.S. tax I.D. No.)

 

and irrevocably appoint _______________
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.

 

	Date:_________________	Your Signature:__________________

 

	Signature Guarantee:	__________________________

 

(Signature must be guaranteed)

 

Sign exactly as your name appears on the
other side of this Security.

 

The signature(s) should be guaranteed by
an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved
signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15.

 

The undersigned hereby certifies that it
 ̈ is /  ̈
is not an Affiliate of the Company and that, to its knowledge, the proposed transferee ❑
is / ❑ is not an Affiliate of the Company.

 

In connection with
any transfer or exchange of any of the Securities evidenced by this certificate occurring prior to the Resale Restriction Termination
Date, the undersigned confirms that such Securities are being:

 

CHECK ONE BOX BELOW:

 

		(1)	 ̈	acquired for the undersigned’s own account, without transfer; or

 

		(2)	 ̈	transferred to the Company; or

 

		(3)	 ̈	transferred pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended (the “Securities
Act”); or

 

		(4)	 ̈	transferred pursuant to an effective registration statement
under the Securities Act; or

 

		(5)	 ̈	transferred pursuant to and in compliance with Regulation
S under the Securities Act; or

 

		(6)	 ̈	transferred to an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities
Act) or an “accredited investor” (as defined in Rule 501(a)(4) under the Securities Act), that has furnished to the
Trustee a signed letter containing certain representations and agreements (the form of which letter appears below); or

 

		(7)	 ̈	transferred pursuant to another available
exemption from the registration requirements of the Securities Act of 1933, as amended.

 

     

     

    

 

Unless one of the boxes
is checked, the Trustee will refuse to register any of the Securities evidenced by this certificate in the name of any person other
than the registered Holder thereof, provided, however, that if box (5), (6) or (7) is checked, the Company may require, prior to
registering any such transfer of the Securities, in its sole discretion, such legal opinions, certifications and other information
as the Company may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act of 1933, as amended, such as the exemption provided by Rule
144 under such Act.

 

	Signature	____________________

 

	Signature Guarantee:	____________________

 

(Signature must be guaranteed)

 

The signature(s) should be guaranteed by
an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved
signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15.

 

TO BE COMPLETED BY PURCHASER IF BOX (1)
OR (3) ABOVE IS CHECKED.

 

The undersigned represents
and warrants that it is purchasing this Security for its own account or an account with respect to which it exercises sole investment
discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under
the Securities Act of 1933, as amended, and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges
that it has received such information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined
not to request such information and that it is aware that the transferor is relying upon the undersigned’s foregoing representations
in order to claim the exemption from registration provided by Rule 144A.

 

	 	Dated:	__________________

 

     

     

    

 

SCHEDULE OF INCREASES AND DECREASES
IN THE GLOBAL SECURITY

 

The following increases
or decreases in the principal amount of this Global Security have been made:

 

	Date	Amount of

 decrease in

 principal amount

 of this Global

 Security	Amount of

 increase in

 principal amount 

of this Global

 Security	Principal amount

 of this Global

 Security following

 such increase or 

decrease	Signature of 

authorized officer

 of Trustee as

 Custodian
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

 

     

     

    

 

[FORM OF LETTER TO BE DELIVERED IN
CONNECTION WITH TRANSFERS

TO ACCREDITED INVESTORS]

 

Business Development Corporation of America  

 

9 West 57th Street, 49th Floor, Suite 4920  

 

New York, New York 10019  

 

Attention: Chief Financial Officer  

 

Facsimile: (844) 643-0430  

 

 

U.S.
Bank National Association

         

        111 Fillmore Ave. E., 2nd Floor

         

        St. Paul, Minnesota 55107

         

        Facsimile: (651) 466-7368

         

        Attention: Corporate Trust, DWAC UNIT

        

 

 

Re: Business Development Corporation of
America (the “Company”)

 

Ladies and Gentlemen:

 

This certificate is delivered to request
a transfer of $[____________] principal amount of the 4.85% Notes due 2024 (the “Securities”) of Business Development
Corporation of America (the “Company”).

 

Upon transfer, the Securities would be
registered in the name of the new beneficial owner as follows:

 

	Name: 	 	 

 

	Address: 	 	 

 

	Taxpayer ID Number: 	 	 

 

The undersigned represents and warrants
to you that:

 

		1.	I am an “accredited investor” (as defined in Rule 501(a)(4) under the U.S. Securities
Act of 1933, as amended (the “Securities Act”)) and I am acquiring the Securities not with a view to, or for
offer or sale in connection with, any distribution in violation of the Securities Act. I have such knowledge and experience in
financial and business matters as to be capable of evaluating the merits and risk of my investment in the Securities and I invest
in or purchase securities similar to the Securities in the normal course of my business. I am able to bear the economic risk of
my investment.

 

     

     

    

 

		2.	I understand that the Securities have not been registered under the Securities Act and, unless
so registered, may not be sold except as permitted in the following sentence. I agree on my own behalf to offer, sell or otherwise
transfer such Securities prior to the Resale Restriction Termination Date only (a) to the Company or any Subsidiary thereof, (b)
pursuant to an effective registration statement under the Securities Act, (c) in a transaction complying with the requirements
of Rule 144A under the Securities Act, to a person I reasonably believe is a “qualified institutional buyer” under
Rule 144A of the Securities Act (a “QIB”) that is purchasing for its own account or for the account of a QIB
and to whom notice is given that the transfer is being made in reliance on Rule 144A, (d) pursuant to offers and sales to non-U.S.
persons that occur outside the United States within the meaning of Regulation S under the Securities Act, (e) to an institutional
“accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act that is purchasing
for its own account or for the account of such an institutional “accredited investor,” in each case for investment
purposes and not with a view to or for offer or sale in connection with any distribution in violation of the Securities Act or
(f) pursuant to any other available exemption from the registration requirements of the Securities Act, subject in each of the
foregoing cases to any requirement of law that the disposition of my property be at all times within my control and in compliance
with any applicable state securities laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction
Termination Date. Each purchaser acknowledges that the Company and the Trustee reserve the right prior to any offer, sale or other
transfer prior to the Resale Restriction Termination Date of the Securities pursuant to clauses (d), (e) or (f) above to require
the delivery of an opinion of counsel, certifications and/or other information satisfactory to the Company and the Trustee.

 

		3.	I understand and acknowledge that upon the issuance thereof, and until such time as the same is
no longer required under applicable requirements of the Securities Act or state securities laws, the Securities that I acquire
will be certificated Securities that will bear, and all certificates issued in exchange therefor or in substitution thereof will
bear, a restrictive legend set forth in Section 203 of the Indenture.

 

		4.	I am [not] an Affiliate of the Company.

 

	 	TRANSFEREE
	 	 
	 	 
	 	[Insert Name of Transferee]
	 	 
	 	 
	 	 
	 	Name:
	 	Title:

 

     

     

    

 

[FORM OF LETTER TO BE DELIVERED IN
CONNECTION WITH TRANSFERS TO INSTITUTIONAL ACCREDITED INVESTORS]

 

Business Development Corporation of America  

 

9 West 57th Street, 49th Floor, Suite 4920  

 

New York, New York 10019

 

Attention: Chief Financial Officer  

 

Facsimile: (844) 643-0430    

 

 

U.S. Bank National Association

 

111 Fillmore Ave. E., 2nd Floor  

 

St. Paul, Minnesota 55107  

 

Facsimile: (651) 466-7368

 

Attention: Corporate Trust, DWAC UNIT    

 

 

Re: Business Development Corporation of
America (the “Company”)

 

Ladies and Gentlemen:

 

This certificate is delivered to request
a transfer of $[___________] principal amount of the 4.85% Notes due 2024 (the “Securities”) of Business Development
Corporation of America (the “Company”).

 

Upon transfer, the Securities would be
registered in the name of the new beneficial owner as follows:

 

	Name: 	 	 

 

	Address: 	 	 

 

	Taxpayer ID Number: 	 	 

 

The undersigned represents and warrants
to you that:

 

		1.	We are an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3)
or (7) under the Securities Act of 1933, as amended (the “Securities Act”)) purchasing for our own account or
for the account of such an institutional “accredited investor,” and we are acquiring the Securities not with a view
to, or for offer or sale in connection with, any distribution in violation of the Securities Act. We have such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and risk of our investment in the Securities and we
invest in or purchase securities similar to the Securities in the normal course of our business. We and any accounts for which
we are acting are each able to bear the economic risk of our or its investment.

 

     

     

    

 

		2.	We understand that the Securities have not been registered under the Securities Act and, unless
so registered, may not be sold except as permitted in the following sentence. We agree on our own behalf and on behalf of any investor
account for which we are purchasing Securities to offer, sell or otherwise transfer such Securities prior to the Resale Restriction
Termination Date only (a) to the Company or any Subsidiary thereof, (b) pursuant to an effective registration statement under the
Securities Act, (c) in a transaction complying with the requirements of Rule 144A under the Securities Act, to a person we reasonably
believe is a “qualified institutional buyer” under Rule 144A of the Securities Act (a “QIB”) that
is purchasing for its own account or for the account of a QIB and to whom notice is given that the transfer is being made in reliance
on Rule 144A, (d) pursuant to offers and sales to non-U.S. persons that occur outside the United States within the meaning of Regulation
S under the Securities Act, (e) to an institutional “accredited investor” within the meaning of Rule 501 (a)(1), (2),
(3) or (7) under the Securities Act that is purchasing for its own account or for the account of such an institutional “accredited
investor,” in each case for investment purposes and not with a view to or for offer or sale in connection with any distribution
in violation of the Securities Act or (f) pursuant to any other available exemption from the registration requirements of the Securities
Act, subject in each of the foregoing cases to any requirement of law that the disposition of property or the property of such
investor account or accounts be at all times within our or their control and in compliance with any applicable state securities
laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction Termination Date. If any resale
or other transfer of the Securities is proposed to be made pursuant to clause (e) above prior to the Resale Restriction Termination
Date, the transferor shall deliver a letter from the transferee substantially in the form of this letter to the Company and the
Trustee, which shall provide, among other things, that the transferee is an institutional “accredited investor” (within
the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) and that it is acquiring such Securities for investment
purposes and not for distribution in violation of the Securities Act. Each purchaser acknowledges that the Company and the Trustee
reserve the right prior to any offer, sale or other transfer prior to the Resale Restriction Termination Date of the Securities
pursuant to clauses (d), (e) or (f) above to require the delivery of an opinion of counsel, certifications and/or other information
satisfactory to the Company and the Trustee.

 

		3.	We [are][are not] an Affiliate of the Company.

 

	 	TRANSFEREE
	 	 
	 	 
	 	[Insert Name of Transferee]
	 	 
	 	 
	 	Name:
	 	Title:

 

     

     

    

 

Exhibit B – Form of IAI Global
Note 

 

BUSINESS DEVELOPMENT CORPORATION OF
AMERICA

 

4.85% Notes due 2024

 

UNLESS THIS CERTIFICATE IS PRESENTED BY
AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW
YORK, TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN
THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE
TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER
USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS
AN INTEREST HEREIN.

 

TRANSFERS OF THIS GLOBAL SECURITY SHALL
BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S
NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS
SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF.

 

THIS SECURITY HAS NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS. NEITHER THIS SECURITY
NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED
OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT.

 

THE HOLDER OF THIS SECURITY BY ITS ACCEPTANCE
HEREOF (1) REPRESENTS THAT IT IS AN INSTITUTIONAL “ACCREDITED INVESTOR” WITHIN
THE MEANING OF SUBPARAGRAPH (a)(1), (2), (3) OR (7) OF RULE 501 UNDER THE SECURITIES ACT, AND (2) AGREES
TO OFFER, SELL OR OTHERWISE TRANSFER SUCH SECURITY, PRIOR TO THE DATE (THE “RESALE RESTRICTION TERMINATION DATE”)
WHICH IS SIX MONTHS (OR SUCH OTHER DATE WHEN RESALES OF SECURITIES BY NON-AFFILIATES ARE FIRST PERMITTED UNDER RULE 144(d)) AFTER
THE LATER OF THE ORIGINAL ISSUE DATE HEREOF (OR ANY PREDECESSOR OF THIS SECURITY) OR THE DATE OF ANY SUBSEQUENT REOPENING OF THE
SECURITIES AND THE LAST DATE ON WHICH THE COMPANY OR ANY AFFILIATE OF THE COMPANY WAS THE OWNER OF THIS SECURITY (OR ANY PREDECESSOR
OF SUCH SECURITY), ONLY (A) TO THE COMPANY OR ANY OF ITS SUBSIDIARIES, (B) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BEEN
DECLARED EFFECTIVE UNDER THE SECURITIES ACT, (C) FOR SO LONG AS THE SECURITIES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A, TO
A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED IN RULE 144A) THAT PURCHASES FOR ITS
OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE
ON RULE 144A, (D) TO AN INSTITUTIONAL “ACCREDITED INVESTOR” WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) UNDER
THE SECURITIES ACT THAT IS NOT A QUALIFIED INSTITUTIONAL BUYER AND THAT IS PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF
ANOTHER INSTITUTIONAL ACCREDITED INVESTOR OR (E) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT AND THE SECURITIES LAWS OF ANY OTHER JURISDICTION, INCLUDING ANY STATE OF THE UNITED STATES, SUBJECT TO THE
COMPANY’S AND THE TRUSTEE’S RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER TO REQUIRE THE DELIVERY OF AN OPINION OF
COUNSEL SATISFACTORY TO EACH OF THEM AND/OR A CERTIFICATE OF TRANSFER OR EXCHANGE IN THE FORM PRESCRIBED IN THE INDENTURE. THIS
LEGEND WILL BE REMOVED UPON THE REQUEST OF THE HOLDER AFTER THE RESALE RESTRICTION TERMINATION DATE.

 

     

     

    

 

BY ITS ACQUISITION AND HOLDING OF THIS
SECURITY, THE HOLDER THEREOF WILL BE DEEMED TO HAVE REPRESENTED, WARRANTED AND AGREED THAT EITHER (I) IT IS NOT AND WILL NOT BE
FOR SO LONG AS IT HOLDS ANY SECURITY (OR INTEREST IN A SECURITY) AN EMPLOYEE BENEFIT PLAN OR ARRANGEMENT SUBJECT TO THE FIDUCIARY
RESPONSIBILITY REQUIREMENT OF TITLE I OF U.S. EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”),
A “PLAN” OR ARRANGEMENT SUBJECT TO SECTION 4975 OF THE U.S. INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”),
OR AN ENTITY WHOSE UNDERLYING ASSETS INCLUDE PLAN ASSETS BY REASON OF SUCH EMPLOYEE BENEFIT PLAN OR PLAN’S INVESTMENT IN
THE ENTITY, OR A GOVERNMENTAL, NON-U.S., CHURCH OR OTHER PLAN WHICH IS SUBJECT TO ANY FEDERAL, STATE, LOCAL, NON-U.S. OR OTHER
LAWS OR REGULATIONS THAT ARE SUBSTANTIALLY SIMILAR TO SUCH PROVISIONS OF ERISA OR THE CODE (“SIMILAR LAWS”),
OR (II) THE PURCHASE, HOLDING AND DISPOSITION OF THIS SECURITY WILL NOT CONSTITUTE A NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION
406 OF ERISA OR SECTION 4975 OF THE CODE OR, IN THE CASE OF A GOVERNMENTAL, NON-U.S., CHURCH OR OTHER PLAN, A SIMILAR VIOLATION
UNDER ANY APPLICABLE SIMILAR LAWS.

 

Business Development Corporation of
America

 

	No. [_____]	 	Principal Amount $[•]
	 	 	 
	ISIN No. US12325JAG67	 	CUSIP No. 12325J AG6

 

4.85% Notes due 2024

 

Business Development
Corporation of America, a corporation duly organized and existing under the laws of Maryland (herein called the “Company”,
which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay
to Cede & Co., or registered assigns, the principal sum of [•] (U.S. $[•]), as revised by the Schedule of Increases
and Decreases in Global Security attached hereto, on December 15, 2024.

 

Interest Payment Dates: June 15 and December
15, commencing on June 15, 2020

 

Record Dates: May 30 and November 30

 

Additional provisions of this Security
are set forth on the other side of this Security.

 

     

     

    

 

 

IN WITNESS WHEREOF,
the Company has caused this Security to be duly executed.

 

	Dated: December 5, 2019	 
		BUSINESS DEVELOPMENT CORPORATION OF AMERICA
	 	 
	 	 
		By:	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	 	 
	Attest:	 	 	 
	Name:	 	 	 
	Title:	 	 	 

 

     

     

    

 

TRUSTEE CERTIFICATE OF AUTHENTICATION

 

This Security is one of the Securities
of the series referred to in the within-mentioned Indenture.

 

	Dated: December 5, 2019	 
		U.S. BANK NATIONAL ASSOCIATION,
	 	as Trustee
	 	 
	 	 
		By:	 
	 	 	Authorized Signatory

 

     

     

    

 

[FORM OF REVERSE SIDE OF SECURITY]

 

Business Development Corporation of America

 

4.85% Notes due 2024

 

Capitalized terms used
herein and not defined herein have the meanings ascribed thereto in the Indenture.

 

1.                  
Interest

 

Business Development
Corporation of America, a Maryland corporation, promises to pay interest on the principal amount of this Security at 4.85% per
annum from December 5, 2019 until maturity. The Company will pay interest semi-annually in arrears every June 15 and December 15
of each year, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment
Date”). Interest on the Securities of this series shall accrue from the most recent date to which interest has been paid
or if no interest has been paid, from the date of issuance; provided, that the first Interest Payment Date shall be June 15, 2020.
The Company shall pay interest on overdue principal at the rate specified herein, and it shall pay interest (including post-petition
interest in any proceeding under any Bankruptcy Law) on overdue installments of interest (without regard to any applicable grace
period) at the same rate to the extent lawful. Interest on the Securities will be computed on the basis of a 360-day year comprised
of twelve 30-day months.

 

2.                  
Method of Payment

 

Payment of interest
on any Security which is payable, and is timely paid or duly provided for, on any Interest Payment Date shall be made at the Corporate
Trust Office of the Trustee in such Currency of the United States of America as at the time of payment is legal tender for payment
of public and private debts. At the option of the Company, all payments of interest may be paid by check to the registered Holder
of the Registered Security or other person entitled thereto against surrender of such Security.

 

Payments of principal
of (and premium, if any, on) and interest, if any, on Securities represented by Global Securities that are registered in the name
of or held by DTC or its nominee shall be made by wire transfer of immediately available funds to the accounts specified by DTC
or its nominee, as the case may be, as the Holder of such Global Securities.

 

No reference herein
to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which
is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate,
and in the coin or currency, herein prescribed.

 

3.                  
Paying Agent and Registrar

 

The Company initially
appoints U.S. Bank National Association (the “Trustee”) as Registrar and Paying Agent for the Securities. The
Company may change any Registrar or Paying Agent without prior notice to the Holders. The Company may act as Paying Agent, Registrar
or transfer agent.

 

4.                  
Indenture

 

The Company issued
the Securities under an Indenture dated as of December 19, 2017 between us and U.S. Bank, as trustee, as supplemented by the third
supplemental indenture between us and U.S. Bank, as trustee, dated as of December 5, 2019 (as it may be further amended or supplemented
from time to time with respect to the Securities in accordance with the terms thereof, the “Indenture”), among
the Company and the Trustee. This Security is one of the series designated on the face hereof. The terms of the Securities include
those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections
77aaa-77bbbb) as in effect on the date of the Indenture (the “Act”). The Securities are subject to all terms
and provisions of the Indenture, and Holders are referred to the Indenture and the Act for a statement of those terms.

 

     

     

    

 

5.                  
Redemption

 

The Securities of this
series are subject to redemption in whole or in part at any time or from time to time, at the option of the Company, at a redemption
price per Security equal to the greater of the following amounts, plus, in each case, accrued and unpaid interest to but excluding
the Redemption Date:

 

		   a.	100% of the principal amount of such Securities to be redeemed plus accrued and unpaid interest
to but excluding the Redemption Date; and

 

		   b.	the sum of the present values of the remaining scheduled payments of principal and interest (exclusive
of accrued and unpaid interest to but excluding the Redemption Date) on the Securities to be redeemed, discounted to the Redemption
Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable Treasury Rate plus
50 basis points.

 

All determinations
with respect to the Redemption Price made by any Reference Treasury Dealer, including the Quotation Agent, shall be final and binding
absent manifest error.

 

Notice of redemption
shall be given in writing and mailed, first-class postage prepaid or by overnight courier guaranteeing next-day delivery, to each
Holder of the Securities to be redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date,
at the Holder’s address appearing in the Security Register. All notices of redemption shall contain the information set forth
in Section 1104 of the Indenture.

 

Any exercise of the
Company’s option to redeem the Securities will be done in compliance with the Investment Company Act of 1940, as amended,
to the extent applicable.

 

If less than all the
Securities of this series issued on the same day with the same terms are to be redeemed, the particular Securities to be redeemed
shall be selected not more than 60 days prior to the Redemption Date by the Trustee in compliance with the requirements of DTC,
from the Outstanding Securities of this series issued on such date with the same terms not previously called for redemption, in
compliance with the requirements of the principal national securities exchange on which the Securities are listed (if the Securities
are listed on any national securities exchange), or if the Securities are not held through DTC or listed on any national securities
exchange, or DTC prescribed no method of selection, on a pro rata basis, or by such method as the Trustee shall deem fair and appropriate
and subject to and otherwise in accordance with the procedures of the applicable Depository; provided that such method complies
with the rules of any national securities exchange or quotation system on which the Securities are listed, and may provide for
the selection for redemption of portions (equal to the minimum authorized denomination for such Securities or any integral multiple
thereof) of the principal amount of Securities of a denomination larger than the minimum authorized denomination for Securities;
provided, however that no such partial redemption shall reduce the portion of the principal amount of a Security not redeemed to
less than $1,000.

 

Unless the Company
defaults in payment of the Redemption Price, on and after the Redemption Date, interest will cease to accrue on the Securities
called for redemption.

 

Notwithstanding the
foregoing, at any time on or after November 15, 2024, the Company may redeem some or all of the Notes at any time, or from time
to time, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed plus accrued and unpaid interest
to, but excluding, the redemption date.

 

6.                  
Repurchase Provisions

 

Holders will have the
right to require the Company to repurchase their Securities upon the occurrence of a Change of Control Repurchase Event as set
forth in the Indenture.

 

     

     

    

 

7.                  
Denominations; Transfer; Exchange

 

As provided in the
Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register,
upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal
of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer
in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized
in writing, and thereupon one or more new Securities of this series of like tenor, of authorized denominations and for the same
aggregate principal amount, will be issued to the designated transferee or transferees.

 

The Securities of this
series are issuable only in registered form without coupons in denominations of $1,000 and any integral multiples of $1,000 in
excess thereof. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are
exchangeable for a like aggregate principal amount of Securities of this series and of like tenor, of a different authorized denomination,
as requested by the Holder surrendering the same.

 

No service charge shall
be made for any such registration of transfer or exchange, but the Company or Trustee may require payment of a sum sufficient to
cover any tax or other governmental charge payable in connection therewith.

 

Prior to due presentment
of this Security for registration of transfer the Company, the Trustee and any agent of the Company or the Trustee may treat the
Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.

 

8.                  
Persons Deemed Owners

 

The registered Holder
of this Security may be treated as the owner of it for all purposes.

 

9.                  
Discharge and Defeasance

 

The Indenture contains
provisions for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of
Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture.

 

10.                
Amendment, Supplement, Waiver

 

Subject to certain
exceptions contained in the Indenture, the Indenture and the Securities of this series may be amended, or a Default thereunder
may be waived, with the consent of the Holders of a majority in aggregate principal amount of the outstanding Securities of this
series. Without notice to or the consent of any Holder, the Company, and the Trustee may amend or supplement the Indenture and
the Securities as provided in the Indenture.

 

11.               
Defaults and Remedies

 

If an Event of Default
(other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization of the Company) with respect
to Securities of this series occurs and is continuing, the Trustee by notice to the Company, or the Holders of at least 25% in
principal amount of the outstanding Securities of this series by notice to the Company and the Trustee, may declare the principal
of, premium, if any, and accrued and unpaid interest, and any other monetary obligations on all the Securities of this series to
be due and payable immediately. Upon the effectiveness of such declaration, such principal, premium, interest and other monetary
obligations will be due and payable immediately. If a bankruptcy, insolvency or reorganization of the Company occurs and is continuing,
the principal of, premium, if any, and accrued and unpaid interest and any other monetary obligations on all the Securities of
this series will become and be immediately due and payable without any declaration or other act on the part of the Trustee or any
Holders. Under certain circumstances, the Holders of a majority in principal amount of the outstanding Securities of this series
may rescind any such acceleration with respect to the Securities of this series and its consequences.

 

     

     

    

 

As provided in and
subject to the provisions of the Indenture, the Holder of this Security shall not have the right to institute any proceeding with
respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder
shall have previously given the Trustee written notice of a continuing Event of Default with respect to the Securities of this
series, the Holders of not less than 25% in principal amount of the Securities of this series at the time Outstanding shall have
made written request to the Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee
indemnity, security, or both, satisfactory to the Trustee, against the costs, expenses and liabilities to be incurred in compliance
with such request, and the Trustee shall not have received from the Holders of a majority in principal amount of Securities of
this series at the time Outstanding a direction inconsistent with such request within sixty (60) days after receipt of such notice,
and the Trustee shall have failed to institute any such proceeding for sixty (60) days after receipt of such notice, request and
offer of indemnity and/or security. The foregoing shall not apply to any suit instituted by the Holder of this Security for the
enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed
herein.

 

12.               
Trustee Dealings with the Company

 

Subject to certain
limitations set forth in the Indenture, the Trustee in its individual or any other capacity may become the owner or pledgee of
Securities and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee.
In addition, the Trustee shall be permitted to engage in transactions with the Company; provided, however, that if the Trustee
acquires any conflicting interest under the TIA, the Trustee must (i) eliminate such conflict within 90 days of acquiring such
conflicting interest or (ii) resign.

 

13.               
No Recourse Against Others

 

No director, manager,
officer, employee, incorporator, shareholder or member of the Company or any of its Subsidiaries or Affiliates, as such, shall
have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect
of, or by reason of such obligations or their creation. Each Holder by accepting a Security waives and releases all such liability.
The waiver and release are part of the consideration for issuance of the Securities. Such waiver may not be effective to waive
liabilities under the U.S. federal securities laws and it is the view of the SEC that such a waiver is against public policy.

 

14.               
Authentication

 

This Security shall
not be valid until an authorized signatory of the Trustee (or an authenticating agent acting on its behalf) manually signs the
certificate of authentication on the other side of this Security.

 

15.               
Abbreviations

 

Customary abbreviations
may be used in the name of a Holder or an assignee, such as TEN COM (= tenants in common), TEN ENT (= tenants by the entirety),
JT TEN (= joint tenants with rights of survivorship and not as tenants in common), CUST (= custodian) and U/G/M/A (= Uniform Gift
to Minors Act).

 

16.               
CUSIP and ISIN Numbers

 

The Company has caused
CUSIP numbers, if applicable, to be printed on the Securities and have directed the Trustee to use CUSIP numbers, if applicable,
in notices of redemption or purchase as a convenience to Holders. No representation is made as to the accuracy of such numbers
either as printed on the Securities or as contained in any notice of redemption or purchase and reliance may be placed only on
the other identification numbers placed thereon.

 

17.               
Governing Law; Conflict; Request for Indenture

 

This Security shall
be governed by, and construed in accordance with, the laws of the State of New York. To the extent any provision of this Security
conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling.

 

     

     

    

 

The Company will furnish
to any Holder upon written request and without charge to the Holder a copy of the Indenture. Requests may be made to:

 

Business Development Corporation of America

 

9 West 57th Street, 49th Floor, Suite 4920

 

New York, New York 10019  

 

Attention: Chief Financial Officer  

 

Facsimile: (844) 643-0430  

 

     

     

    

 

[ASSIGNMENT FORM]

 

To assign this Security, fill in
the form below:

 

I or we assign and transfer this Security
to:

 

(Print or type assignee’s name, address
and zip code)

 

(Insert assignee’s social security
or U.S. tax I.D. No.)

 

and irrevocably appoint _______________
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.

 

Date:_________________                Your Signature:        __________________

 

Signature Guarantee:          __________________________

 

(Signature must be guaranteed)

 

Sign exactly as your name appears on the
other side of this Security.

 

The signature(s) should be guaranteed by
an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved
signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15.

 

The undersigned hereby certifies that it
 ̈ is /  ̈
is not an Affiliate of the Company and that, to its knowledge, the proposed transferee  ̈
is /  ̈ is not an Affiliate of the Company.

 

In connection with
any transfer or exchange of any of the Securities evidenced by this certificate occurring prior to the Resale Restriction Termination
Date, the undersigned confirms that such Securities are being:

 

CHECK ONE BOX BELOW:

 

		(1)	 ̈	acquired for the undersigned’s
own account, without transfer; or

 

		(2)	 ̈	transferred to the
Company; or

 

		(3)	 ̈	transferred pursuant
to and in compliance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”); or

 

		(4)	 ̈	transferred pursuant
to an effective registration statement under the Securities Act; or

 

		(5)	 ̈	transferred pursuant
to and in compliance with Regulation S under the Securities Act; or

 

		(6)	 ̈	transferred
to an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act)
or an “accredited investor” (as defined in Rule 501(a)(4) under the Securities Act), that has furnished to the Trustee
a signed letter containing certain representations and agreements (the form of which letter appears below); or

 

		(7)	 ̈	transferred pursuant
to another available exemption from the registration requirements of the Securities Act of 1933, as amended.

 

     

     

    

 

Unless one of the boxes
is checked, the Trustee will refuse to register any of the Securities evidenced by this certificate in the name of any person other
than the registered Holder thereof, provided, however, that if box (5), (6) or (7) is checked, the Company may require, prior to
registering any such transfer of the Securities, in its sole discretion, such legal opinions, certifications and other information
as the Company may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act of 1933, as amended, such as the exemption provided by Rule
144 under such Act.

 

Signature               ____________________

 

Signature Guarantee:          _________________________

 

(Signature must be guaranteed)

 

The signature(s) should be guaranteed by
an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved
signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15.

 

TO BE COMPLETED BY PURCHASER IF BOX (1)
OR (3) ABOVE IS CHECKED.

 

The undersigned represents
and warrants that it is purchasing this Security for its own account or an account with respect to which it exercises sole investment
discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under
the Securities Act of 1933, as amended, and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges
that it has received such information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined
not to request such information and that it is aware that the transferor is relying upon the undersigned’s foregoing representations
in order to claim the exemption from registration provided by Rule 144A.

 

Dated:     __________________

 

     

     

    

 

SCHEDULE OF INCREASES AND DECREASES
IN THE GLOBAL SECURITY

 

The following increases
or decreases in the principal amount of this Global Security have been made:

 

	Date	Amount of

 decrease in

 principal amount

 of this Global 

Security	Amount of

 increase in

 principal amount

 of this Global

 Security	Principal amount 

of this Global

 Security following

 such increase or

 decrease	Signature of 

authorized officer

 of Trustee as 

Custodian
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

 

     

     

    

 

[FORM OF LETTER TO BE DELIVERED IN
CONNECTION WITH TRANSFERS TO ACCREDITED INVESTORS]

 

	Business Development Corporation of America

                                                                                 

                                                                                9 West 57th Street, 49th Floor, Suite 4920

                                                                                 

                                                                                New York, New York 10019

                                                                                 

                                                                                Attention: Chief Financial Officer

                                                                                 

                                                                                Facsimile: (844) 643-0430

                                                                                 

                                                                                

	 
	U.S. Bank National Association

                                                                            

                                                                           111 Fillmore Ave. E., 2nd Floor

                                                                            

                                                                           St. Paul, Minnesota 55107

                                                                            

                                                                           Facsimile: (651) 466-7368

                                                                            

                                                                           Attention: Corporate Trust, DWAC UNIT

                                                                            

 

Re: Business Development Corporation of
America (the “Company”)

 

Ladies and Gentlemen:

 

This certificate is delivered to request
a transfer of $[____________] principal amount of the 4.85% Notes due 2024 (the “Securities”) of Business Development
Corporation of America (the “Company”).

 

Upon transfer, the Securities would be
registered in the name of the new beneficial owner as follows:

 

	Name:	 	 

 

	Address:	 	 

 

 

	Taxpayer ID Number:	 	 

 

The undersigned represents and warrants
to you that:

 

		1.	I am an “accredited investor” (as defined in Rule 501(a)(4) under the U.S. Securities
Act of 1933, as amended (the “Securities Act”)) and I am acquiring the Securities not with a view to, or for
offer or sale in connection with, any distribution in violation of the Securities Act. I have such knowledge and experience in
financial and business matters as to be capable of evaluating the merits and risk of my investment in the Securities and I invest
in or purchase securities similar to the Securities in the normal course of my business. I am able to bear the economic risk of
my investment.

 

     

     

    

 

		2.	I understand that the Securities have not been registered under the Securities Act and, unless
so registered, may not be sold except as permitted in the following sentence. I agree on my own behalf to offer, sell or otherwise
transfer such Securities prior to the Resale Restriction Termination Date only (a) to the Company or any Subsidiary thereof, (b)
pursuant to an effective registration statement under the Securities Act, (c) in a transaction complying with the requirements
of Rule 144A under the Securities Act, to a person I reasonably believe is a “qualified institutional buyer” under
Rule 144A of the Securities Act (a “QIB”) that is purchasing for its own account or for the account of a QIB
and to whom notice is given that the transfer is being made in reliance on Rule 144A, (d) pursuant to offers and sales to non-U.S.
persons that occur outside the United States within the meaning of Regulation S under the Securities Act, (e) to an institutional
“accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act that is purchasing
for its own account or for the account of such an institutional “accredited investor,” in each case for investment
purposes and not with a view to or for offer or sale in connection with any distribution in violation of the Securities Act or
(f) pursuant to any other available exemption from the registration requirements of the Securities Act, subject in each of the
foregoing cases to any requirement of law that the disposition of my property be at all times within my control and in compliance
with any applicable state securities laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction
Termination Date. Each purchaser acknowledges that the Company and the Trustee reserve the right prior to any offer, sale or other
transfer prior to the Resale Restriction Termination Date of the Securities pursuant to clauses (d), (e) or (f) above to require
the delivery of an opinion of counsel, certifications and/or other information satisfactory to the Company and the Trustee.

 

		3.	I understand and acknowledge that upon the issuance thereof, and until such time as the same is
no longer required under applicable requirements of the Securities Act or state securities laws, the Securities that I acquire
will be certificated Securities that will bear, and all certificates issued in exchange therefor or in substitution thereof will
bear, a restrictive legend set forth in Section 203 of the Indenture.

 

		4.	I am [not] an Affiliate of the Company.

 

	 	TRANSFEREE
	 	 
	 	[Insert Name of Transferee] 
	 	 
	 	 
	 	Name:
	 	Title:

 

     

     

    

 

[FORM OF LETTER TO BE DELIVERED IN
CONNECTION WITH TRANSFERS TO INSTITUTIONAL ACCREDITED INVESTORS]

 

	Business Development Corporation of America

                                                                                 

                                                                                9 West 57th Street, 49th Floor, Suite 4920

                                                                                 

                                                                                New York, New York 10019

                                                                                 

                                                                                Attention: Chief Financial Officer

                                                                                 

                                                                                Facsimile: (844) 643-0430

                                                                                 

                                                                                

	 
	U.S. Bank National Association

                                                                                 

                                                                                111 Fillmore Ave. E., 2nd Floor

                                                                                 

                                                                                St. Paul, Minnesota 55107

                                                                                 

                                                                                Facsimile: (651) 466-7368

                                                                                 

                                                                                Attention: Corporate Trust, DWAC UNIT

 

 

Re: Business Development Corporation of
America (the “Company”)

 

Ladies and Gentlemen:

 

This certificate is delivered to request
a transfer of $[___________] principal amount of the 4.85% Notes due 2024 (the “Securities”) of Business Development
Corporation of America (the “Company”).

 

Upon transfer, the Securities would be
registered in the name of the new beneficial owner as follows:

 

	Name:	 	 

 

	Address:	 	 

 

 

	Taxpayer ID Number:	 	 

 

The undersigned represents and warrants
to you that:

 

		1.	We are an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3)
or (7) under the Securities Act of 1933, as amended (the “Securities Act”)) purchasing for our own account or
for the account of such an institutional “accredited investor,” and we are acquiring the Securities not with a view
to, or for offer or sale in connection with, any distribution in violation of the Securities Act. We have such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and risk of our investment in the Securities and we
invest in or purchase securities similar to the Securities in the normal course of our business. We and any accounts for which
we are acting are each able to bear the economic risk of our or its investment.

 

     

     

    

 

		2.	We understand that the Securities have not been registered under the Securities Act and, unless
so registered, may not be sold except as permitted in the following sentence. We agree on our own behalf and on behalf of any investor
account for which we are purchasing Securities to offer, sell or otherwise transfer such Securities prior to the Resale Restriction
Termination Date only (a) to the Company or any Subsidiary thereof, (b) pursuant to an effective registration statement under the
Securities Act, (c) in a transaction complying with the requirements of Rule 144A under the Securities Act, to a person we reasonably
believe is a “qualified institutional buyer” under Rule 144A of the Securities Act (a “QIB”) that
is purchasing for its own account or for the account of a QIB and to whom notice is given that the transfer is being made in reliance
on Rule 144A, (d) pursuant to offers and sales to non-U.S. persons that occur outside the United States within the meaning of Regulation
S under the Securities Act, (e) to an institutional “accredited investor” within the meaning of Rule 501 (a)(1), (2),
(3) or (7) under the Securities Act that is purchasing for its own account or for the account of such an institutional “accredited
investor,” in each case for investment purposes and not with a view to or for offer or sale in connection with any distribution
in violation of the Securities Act or (f) pursuant to any other available exemption from the registration requirements of the Securities
Act, subject in each of the foregoing cases to any requirement of law that the disposition of property or the property of such
investor account or accounts be at all times within our or their control and in compliance with any applicable state securities
laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction Termination Date. If any resale
or other transfer of the Securities is proposed to be made pursuant to clause (e) above prior to the Resale Restriction Termination
Date, the transferor shall deliver a letter from the transferee substantially in the form of this letter to the Company and the
Trustee, which shall provide, among other things, that the transferee is an institutional “accredited investor” (within
the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) and that it is acquiring such Securities for investment
purposes and not for distribution in violation of the Securities Act. Each purchaser acknowledges that the Company and the Trustee
reserve the right prior to any offer, sale or other transfer prior to the Resale Restriction Termination Date of the Securities
pursuant to clauses (d), (e) or (f) above to require the delivery of an opinion of counsel, certifications and/or other information
satisfactory to the Company and the Trustee.

 

		3.	We [are][are not] an Affiliate of the Company.

 

	 	TRANSFEREE
	 	 
	 	[Insert Name of Transferee] 
	 	 
	 	 
	 	Name:
	 	Title:Exhibit 4.5

 

BUSINESS DEVELOPMENT CORPORATION OF AMERICA

(a Maryland corporation)

 

$100,000,000

4.85% Notes
due 2024

($1,000 Denominations) 

 

PURCHASE AGREEMENT

 

	Sandler O’Neill & Partners, L.P.	 	 	December 3, 2019

1251 Avenue of the Americas

Sixth Floor

New York, New York 10020

 

Ladies and Gentlemen:

 

Business Development
Corporation of America, a Maryland corporation (the “Company”) and BDCA Adviser, LLC, a Delaware limited
liability company (the “Adviser”), address you as the Initial Purchaser (as defined below). The Company
proposes to sell to Sandler O’Neill & Partners, L.P. (the “Initial Purchaser”) $100,000,000 aggregate principal
amount of senior unsecured notes, due December 15, 2024 (the “Securities”).

 

The Securities will
be issued pursuant to the provisions of the indenture, dated as of December 19, 2017 (the “Base Indenture”),
between the Company and U.S. Bank National Association, a national banking association, as trustee (the “Trustee”),
as supplemented by the third supplemental indenture, dated as of December 5, 2019 (the “Third Supplemental Indenture”
and together with the Base Indenture, the “Indenture”).

 

The Company understands
that the Initial Purchaser proposes to make an offering of the Securities on the terms and in the manner set forth herein and agrees
that the Initial Purchaser may resell, subject to the conditions set forth herein, all or a portion of the Securities to qualified
institutional buyers and institutional accredited investors (“Subsequent Purchasers”) at any time after
this Agreement has been executed and delivered. The Securities are to be offered and sold through the Initial Purchaser without
being registered under the Securities Act of 1933, as amended, and the rules and regulations thereunder (the “1933
Act”), in reliance upon the exemption from such registration afforded by Rule 144A of the 1933 Act (“Rule 144A”).
Pursuant to the terms of the Securities and the Indenture, investors (including the Initial Purchaser) that acquire Securities
may only resell or otherwise transfer such Securities if such Securities are hereafter registered for resale under the 1933 Act
or if an exemption from the registration requirements of the 1933 Act is available (including the exemption afforded by Rule 144A).

 

In connection with
the sale of the Securities, the Company has prepared and delivered to the Initial Purchaser physical or electronic copies of a
preliminary offering memorandum dated November 26, 2019 (including the documents incorporated therein by reference, the “Preliminary
Offering Memorandum”) and will prepare and deliver to the Initial Purchaser, not later than the second business day
following the date hereof, physical or electronic copies of a final offering memorandum (including the documents incorporated therein
by reference, the “Final Offering Memorandum”), each for use by the Initial Purchaser in connection with
its solicitation of purchases of, or offering of, the Securities. “Offering Memorandum” means, with respect
to any date or time referred to in this Agreement, the most recent offering memorandum (whether the Preliminary Offering Memorandum
or the Final Offering Memorandum, in each case including any amendment or supplement to either document), including exhibits thereto
and any documents incorporated therein by reference, which has been prepared and delivered by the Company to the Initial Purchaser
in connection with its solicitation of purchases of, or offering of, the Securities. “Disclosure Package”
shall mean the Preliminary Offering Memorandum together with the written information set forth in the Pricing Term Sheet attached
hereto as Exhibit A.

 

    

    

    

 

The Company has entered
into: (i) an Investment Advisory and Management Services Agreement with the Adviser, dated February 1, 2019 (the “Advisory
Agreement”); (ii) an Administration Agreement with Benefit Street Partners L.L.C., dated November 1, 2016
(the “Administration Agreement”); and (iii) a Custody Agreement with U.S. Bank National Association,
dated August 13, 2012, as amended (the “Custodian Agreement”). Collectively, the Advisory Agreement,
the Administration Agreement and the Custodian Agreement are herein referred to as the “Company Agreements.”
In addition, the Company has adopted a distribution reinvestment plan pursuant to which the holders of common stock of the Company
shall have their dividends automatically reinvested in additional shares of common stock of the Company unless they elect to receive
such dividends in cash.

 

1.           
Representations and Warranties of the Company and the Adviser. The Company
and the Adviser, jointly and severally, represent and warrant to, and agree with, the Initial Purchaser as set forth below in this
Section 1:

 

(a)             The Disclosure Package, as of 4:00 p.m., Eastern Standard Time, on December 3, 2019 (the “Time of Sale”)
does not, and the Final Offering Memorandum as of its date and as of the Closing Date will not, include any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions from the Disclosure
Package or the Final Offering Memorandum based upon and in conformity with written information furnished by the Initial Purchaser
specifically for use therein, it being understood and agreed that the only such information furnished by the Initial Purchaser
consists of the information described as such in the last sentence of Section 9(b) hereof.

 

(b)             Neither the Company nor the Adviser (including their agents and representatives, other than the Initial Purchaser) has prepared,
made, used, authorized, approved, referred to or distributed, nor will it prepare, make, use, authorize, approve, refer to or distribute,
any written communication that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication
by the Company or its agents and representatives, including in items (iii) and (iv) below, an “Issuer Written Communication”)
other than (i) the Disclosure Package, (ii) the Final Offering Memorandum, (iii) any electronic road show or other written communications,
and (iv) the documents listed on Schedule IV hereto, in each case used in accordance with Sections 1(r) and 5(b). Each such
Issuer Written Communication, when taken together with the Disclosure Package, did not, as of its date and as of the Time of Sale,
and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

(c)             The capitalization of the Company as of the Closing Date is as set forth under the heading “Capitalization”
in the Disclosure Package and the Final Offering Memorandum. All of the issued and outstanding equity interests of the Company
have been duly authorized and validly issued, are fully paid and nonassessable, have been issued in compliance with federal and
state securities laws and were not issued in violation of any preemptive, right of first refusal, or similar right. Attached as
Schedule II is a true and complete list of each entity in which the Company has a direct or indirect majority equity
or voting interest that is consolidated with the Company for financial reporting purposes under generally accepted accounting principles
in the United States (each, a “Subsidiary” and, together, the “Subsidiaries”)
and their jurisdictions of organization. All of the issued and outstanding equity interests of each Subsidiary have been duly and
validly authorized and issued, are fully paid and nonassessable, have been issued in compliance with federal and state securities
laws, were not issued in violation of any preemptive, right of first refusal, or similar right and, except as set forth in the
Final Offering Memorandum, are owned, directly or indirectly, by the Company free and clear of all liens. Except as set forth in
the Final Offering Memorandum, there are no outstanding options, warrants or other rights to acquire or purchase, or instruments
convertible into or exchangeable for, any equity interests of the Company.

 

    2

    

    

 

(d)             Each of the Company and each Subsidiary is a corporation, limited liability company or other entity duly organized and validly
existing in good standing under the laws of the jurisdiction of its organization with full corporate, limited liability or requisite
other power and authority to own, lease and operate its properties and assets and to conduct its business as described in the Disclosure
Package and the Final Offering Memorandum, and is duly qualified to conduct business as a foreign corporation and is in good standing
under the laws of each jurisdiction which requires such qualifications, except where the failure to be so qualified and in good
standing would not, individually or in the aggregate, have a material adverse effect on (i) the performance of this Agreement or
the consummation of any of the transactions herein contemplated or (ii) the condition (financial or otherwise), earnings or business
of the Company and its Subsidiaries, considered as one enterprise, whether or not arising from transactions in the ordinary course
of business (a “Material Adverse Effect”).

 

(e)             The statements in the Disclosure Package and the Final Offering Memorandum under the headings “Description of the
Notes,” “Description of our Other Securities” and “Certain U.S. Federal Income Tax Considerations”
fairly summarize in all material respects the matters therein described.

 

(f)              The execution and delivery of, and the performance by the Company of its obligations under, this Agreement and the Indenture
have been duly and validly authorized by the Company, and this Agreement and the Indenture have been duly executed and delivered
by the Company and, assuming due execution and delivery hereof by you and thereof by the counterparties thereto, the Indenture
constitutes the valid and legally binding agreement of the Company, enforceable against the Company in accordance with its terms,
except as rights to indemnity and contribution thereunder may be limited by federal or state securities laws or principles of public
policy and subject to the qualification that the enforceability of the Company’s obligations thereunder may be limited by
bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium and other laws relating to or affecting creditors’
rights generally and by general equitable principles, regardless whether enforcement is considered in a proceeding in equity or
at law.

 

(g)             The Company is a closed-end, non-diversified management investment company and has elected to be treated as a business development
company under the Investment Company Act of 1940, as amended, and the rules and regulations thereunder (the “1940 Act”),
has duly filed the Notification of Election with the United States Securities and Exchange Commission (the “Commission”).

 

(h)             The Securities to be issued and sold by the Company to the Initial Purchaser hereunder have been duly and validly authorized
and, when issued, authenticated and delivered against payment therefor in accordance with this Agreement and the Indenture, will
constitute valid and binding obligations of the Company and will be in the form contemplated by, and entitled to the benefits of,
the Indenture; and the Securities will conform in all material respects to the description thereof contained in the Indenture,
the Disclosure Package and the Final Offering Memorandum (and any amendment or supplement to any of them). Upon payment for and
delivery of the Securities to be sold by the Company pursuant to this Agreement, the Initial Purchaser will acquire good and valid
title to the Securities, in each case free and clear of all liens, encumbrances, equities, preemptive rights, subscription rights,
or any other claim of any third party.

 

    3

    

    

 

(i)              No consent, approval, authorization, filing with or order of any court or governmental agency or body is required in connection
with the transactions contemplated herein, in the Company Agreements or in the Indenture, other than (i) those under the 1933 Act
or state securities or blue sky laws of any jurisdiction in connection with the purchase and distribution of the Securities by
the Initial Purchaser in the manner contemplated in this Agreement and in the Disclosure Package and the Final Offering Memorandum,
(ii) any necessary approval of the Corporate Financing Department of the Financial Industry Regulatory Authority, Inc. (“FINRA”),
and (iii) such other approvals as have been obtained, it being understood and agreed that for purposes of this representation and
warranty, the transactions contemplated under the Advisory Agreement do not include any prospective investment transactions generally
authorized therein.

 

(j)              Subsequent to the respective dates as of which information is given in the Disclosure Package and the Final Offering Memorandum
(exclusive of any amendments or supplements thereto subsequent to the date of this Agreement): (i) there has been no Material Adverse
Effect; and (ii) none of the Company nor its Subsidiaries (considered as one enterprise) has incurred any material liability or
obligation, indirect, direct or contingent, not in the ordinary course of business nor entered into any material transaction or
agreement not in the ordinary course of business.

 

(k)             Neither the issuance and sale of the Securities, the execution, delivery or performance of this Agreement, the Indenture
or any of the Company Agreements by the Company, nor the consummation by the Company of the transactions herein or therein contemplated
(i) conflicts or will conflict with or constitutes or will constitute a breach of the charter, bylaws or other organizational documents
of the Company or any Subsidiary, (ii) conflicts or will conflict with or constitutes or will constitute a breach of or a
default under, any material agreement, indenture, lease or other instrument to which the Company is a party or by which it or any
of its properties may be bound, except for such conflicts that would not result in a Material Adverse Effect or (iii) violates
or will violate any material statute, law, regulation or filing or judgment, injunction, order or decree applicable to the Company
or any of its properties or will result in the creation or imposition of any lien, charge or encumbrance upon any property or assets
of the Company pursuant to the terms of any agreement or instrument to which it is a party or by which it may be bound or to which
any of the property or assets of the Company is subject, except for such violations that would not result in a Material Adverse
Effect.

 

(l)              There are no contracts, agreements or understandings between the Company and any person granting such person the right to
require the Company to include any securities of the Company owned or to be owned by such person in the securities offered pursuant
to the Disclosure Package and the Final Offering Memorandum.

 

(m)            The financial statements, together with related schedules and notes, included or incorporated by reference in the Disclosure
Package and the Final Offering Memorandum, present fairly in all material respects the financial condition, results of operations
and cash flows of the Company as of the dates and for the periods indicated, comply as to form with the applicable accounting requirements
of the 1933 Act and the 1940 Act and have been prepared in conformity with generally accepted accounting principles applied on
a consistent basis throughout the periods involved (except as otherwise noted therein); and the other financial and statistical
information and data included in the Disclosure Package and the Final Offering Memorandum are accurately derived from such financial
statements and the books and records of the Company.

 

    4

    

    

 

(n)             No action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Company or its property is pending or, to the best knowledge of the Company, threatened that would reasonably be expected to
have a Material Adverse Effect.

 

(o)             The Company owns or leases all such properties as are necessary to the conduct of its operations as presently conducted.

 

(p)             Neither the Company nor any Subsidiary is (i) in violation of its charter, bylaws or other organizational document, (ii)
in breach or default in the performance of the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement,
loan agreement or other agreement, obligation, condition, covenant or instrument to which it is a party or bound or to which its
property is subject, except for such breaches or defaults that would not result in a Material Adverse Effect or (iii) in violation
of any law, ordinance, administrative or governmental rule or regulation applicable to any of their or of any decree of the Commission,
FINRA, any state securities commission, any national securities exchange, any arbitrator, any court or any other governmental,
regulatory, self-regulatory or administrative agency or any official having jurisdiction over the Company or its Subsidiaries,
except for such violations that would not result in a Material Adverse Effect.

 

(q)             Ernst & Young LLP is the independent registered public accounting firm with respect to the Company within the meaning
of the 1933 Act. Ernst & Young LLP has been selected and ratified by the board of directors and stockholders of the Company
in compliance with Section 32 of the 1940 Act. During the periods covered by their respective reports in the Disclosure Package
and Final Offering Memorandum, each of Ernst & Young LLP and KPMG LLP was the independent registered public accounting firm
with respect to the Company within the meaning of the 1933 Act.

 

(r)              The Company has not distributed and, prior to the later to occur of (i) the Closing Date and (ii) completion of the distribution
of the Securities, will not distribute any offering material in connection with the offering and sale of the Securities other than
the Disclosure Package, the documents listed on Schedule IV hereto, and any electronic road show in compliance with the
next sentence, and the Final Offering Memorandum. Before making, preparing, using, authorizing, approving or referring to any Issuer
Written Communication, the Company will furnish to the Initial Purchaser and its counsel a copy of such Issuer Written Communication
for review and will not make, prepare, use, authorize or refer to such written communication to which the Initial Purchaser reasonably
objects.

 

(s)             There
are no transfer taxes or other similar fees or charges under federal law required to be paid in connection with the execution
and delivery of this Agreement or the issuance by the Company or sale by the Company of the Securities.

 

(t)              Each of the Company and its Subsidiaries has filed all material foreign, federal, state and local tax returns that are required
to be filed or has requested extensions thereof (except in any case in which the failure so to file would not have a Material Adverse
Effect) and has paid all taxes required to be paid by it and any other assessment, fine or penalty levied against it, to the extent
that any of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being contested
in good faith or as would not have a Material Adverse Effect.

 

    5

    

    

 

(u)             The Company’s directors and officers/errors and omissions insurance policy and its fidelity bond required by Rule
17g-1 of the 1940 Act are in full force and effect; the Company is in compliance with the terms of such policy and fidelity bond
in all material respects; and there are no claims by the Company under any such policy or fidelity bond; the Company has not been
refused any insurance coverage sought or applied for; and the Company has no reason to believe that it will not be able to renew
its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be
necessary to continue its business at a cost that would not have a Material Adverse Effect.

 

(v)             Each of the Company and its Subsidiaries has such licenses, permits and authorizations of governmental or regulatory authorities
as are necessary to own its property and assets and to conduct its business in the manner described in the Disclosure Package and
the Final Offering Memorandum, except where the failure to obtain such licenses, permits or authorizations would not have a Material
Adverse Effect; the Company and its Subsidiaries have fulfilled and performed all their respective material obligations with respect
to such licenses, permits or authorizations, and no event has occurred which allows, or after notice or lapse of time would allow,
revocation or termination thereof or results in any other material impairment of the rights of the Company under any such licenses,
permits or authorizations.

 

(w)            Assuming that the Initial Purchaser complies with Section 7 hereof, the Securities are eligible for resale pursuant to Rule
144A, and there are no securities of the Company that are listed on a national securities exchange registered under Section 6
of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”)
or that are quoted in a United States automated interdealer quotation system of the same class within the meaning of Rule 144A
as the Securities.

 

(x)              The Company maintains and will maintain a system of internal accounting controls sufficient to provide reasonable assurances
that: (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles,
to calculate net asset value, to maintain accountability for assets; (iii) access to assets is permitted only in accordance
with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing
assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

(y)             The Company has not taken, directly or indirectly, any action designed to or that would constitute or that might reasonably
be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Securities, and the Company is not aware of any such action taken or to
be taken by any affiliates of the Company.

 

(z)              The Company has established and shall maintain disclosure controls and procedures (as defined in Rule 13a-15 and 15d-15
under the Exchange Act), which: (i) are designed to ensure that material information relating to the Company is made known to the
Company’s principal executive officer and its principal financial officer by others within the Company, particularly during
the periods in which the periodic reports required under the Exchange Act are being prepared; and (ii) are effective in all material
respects to perform the functions for which they were established.

 

    6

    

    

 

(aa)           The terms of the Advisory Agreement, including compensation terms, comply in all material respects with the provisions of
Sections 15(a) and 15(c) of the 1940 Act (as applicable to business development companies) and Section 205 of the Investment
Advisers Act of 1940, as amended, and the rules and regulations thereunder (the “Advisers Act”).

 

(bb)          The approvals by the board of directors of the Company of the Advisory Agreement have been made in accordance with the requirements
of Section 15(c) of the 1940 Act applicable to companies that have elected to be regulated as business development companies
under the 1940 Act.

 

(cc)           The Company is not and, after giving effect to the offering and sale of the Securities, will not be required to register
as an “investment company” or an entity “controlled” by an “investment company,” as such terms
are used under the 1940 Act.

 

(dd)           Except as disclosed in the Disclosure Package and Final Offering Memorandum (i) no person is serving or acting as an officer,
director or investment adviser of the Company, except in accordance with the provisions of the 1940 Act and the applicable published
rules and regulations thereunder and (ii) to the knowledge of the Company and based on information available to the Company regarding
the Initial Purchaser, no director of the Company is an “affiliated person” (as defined in the 1940 Act) of the Initial
Purchaser; for purposes of this Section 1(dd), the Company shall be entitled to reasonably rely on representations from such
officers and directors.

 

(ee)           There are no business relationships or related-party transactions involving the Company, any Subsidiary or any other person
required to be described in the Disclosure Package and Final Offering Memorandum which have not been described as required, it
being understood and agreed that the Company and the Adviser make no representation or warranty with respect to any such relationships
involving the Initial Purchaser and any third party that have not been disclosed to the Company.

 

(ff)             The operations of the Company are in material compliance with the provisions of the 1940 Act applicable to business development
companies and the rules and regulations of the Commission thereunder; provided that the Company does not represent or warrant
as to the compliance of Section 9(a) with Section 17(i) of the 1940 Act.

 

(gg)           The Company has made an election under Section 851(b) of the Internal Revenue Code of 1986, as amended, and the rules
and regulations thereunder (the “Code”), to be treated as a regulated investment company (“RIC”)
for federal income tax purposes.

 

(hh)           The conduct by the Company or any Subsidiary of their respective business (as described in the Disclosure Package and the
Final Offering Memorandum) does not require it to be the owner, possessor or licensee of any patents, patent licenses, trademarks,
service marks or trade names which it does not own, possess or license, except to the extent that a lack of such ownership, possession
or license could not reasonably be expected to have a Material Adverse Effect.

 

(ii)             To the Company’s knowledge, neither the Company, any Subsidiary nor any employee or agent of the Company or any Subsidiary
has made any payment of funds of the Company or any Subsidiary or received or retained any funds in violation of any law, rule
or regulation, which payment, receipt or retention of funds is of a character required to be disclosed in the Disclosure Package
and the Final Offering Memorandum.

 

    7

    

    

 

(jj)             Neither the Company nor any Subsidiary (i) has any material lending or other relationship with any bank or lending affiliate
of the Initial Purchaser, except as disclosed in the Disclosure Package and the Final Offering Memorandum and (ii) intends to use
any of the proceeds from the sale of the Securities hereunder, except as disclosed in the Disclosure Package and the Final Offering
Memorandum.

 

(kk)           The Company, and to its knowledge, its directors and officers (in their capacities as such) are in compliance in all material
respects with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated
in connection therewith (the “Sarbanes-Oxley Act”), including Sections 302 and 906 related to certifications.

 

(ll)             The operations of the Company and the Subsidiaries are and have been conducted at all times in compliance in all material
respects with any applicable financial recordkeeping and reporting requirements of The Bank Secrecy Act of 1970, as amended (including
amendments pursuant to the International Money Laundering Abatement and Anti-Terrorist Financing Act of 2001), the money laundering
statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines,
issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”)
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Company with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

(mm)         Neither the Company, any Subsidiary nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate
of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control
of the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds
of the offering, or lend, contribute or otherwise make available such proceeds to any other person or entity, for the purpose of
financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.

 

(nn)           Neither the Company, any Subsidiary nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate
of the Company or any Subsidiary is aware of or has taken any action, directly or indirectly, that would result in a violation
by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”),
including, without limitation, making use of the mails or any means or instrumentality of interstate commerce in furtherance of
an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization
of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political
party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company, any Subsidiary,
and, to the knowledge of the Company, their respective affiliates have conducted their businesses in compliance with the FCPA and
have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure,
continued compliance therewith.

 

(oo)           Neither the Company nor any of its affiliates, as such term is defined in Rule 501(b) under the 1933 Act (each, an “Affiliate”),
has, directly or indirectly, solicited any offer to buy, sold or offered to sell or otherwise negotiated in respect of, or will
solicit any offer to buy, sell or offer to sell or otherwise negotiate in respect of, in the United States or to any United States
citizen or resident, any security which is or would be integrated with the sale of the Securities in a manner that would require
the Securities to be registered under the 1933 Act.

 

    8

    

    

 

(pp)           As of the date hereof, the Company does not have, and at the Closing Date, the Company will not have, any employees. To
the knowledge of the Company, no labor dispute with the employees of the Adviser exists or is imminent.

 

(qq)           Except as contemplated by this Agreement, neither the Company, nor any of its Affiliates or any person acting on its or
any of their behalf (other than the Initial Purchaser, as to whom the Company makes no representation) has offered or sold the
Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) under the 1933
Act.

 

(rr)             As of September 30, 2019, the Company had good and valid title to each investment described in the Disclosure Package and
the Final Offering Memorandum under the Consolidated Schedules of Investments as of September 30, 2019 with corporations or
other entities (each a “Portfolio Company”), free and clear of any liens (except liens disclosed in the
Disclosure Package and Final Offering Memorandum); all of the applicable investment documents and agreements governing such loans
(the “Investment Documents and Agreements”) are in full force and effect; and the Company has no notice
of any material claim of any sort that has been asserted by anyone adverse to the right of the Company under the Investment Documents
and Agreements, or affecting or questioning the rights of the Company under any of the Investment Documents and Agreements; except
as disclosed in the Disclosure Package and the Final Offering Memorandum, each Portfolio Company is current with all of its obligations
under the applicable Investment Documents and Agreements and no event of default (or a default which with the giving of notice
or the passage of time would become an event of default) has occurred or is continuing under such Investment Documents and Agreements.

 

(ss)           Subject
to compliance by the Initial Purchaser with the procedures set forth in Section 3 hereof, it is not necessary in connection
with the offer, sale and delivery of the Securities to the Initial Purchaser and to each Subsequent Purchaser in the manner contemplated
by this Agreement, the Disclosure Package and the Final Offering Memorandum to register the Securities under the 1933 Act or to
qualify the Indenture under the Trust Indenture Act of 1939, as amended.

 

Any certificate signed
by any officer of the Company and delivered to the Initial Purchaser or its counsel in connection with the offering of the Securities
shall be deemed a representation and warranty by the Company as to matters covered therein to the Initial Purchaser.

 

2.           
Representations and Warranties of the Adviser. The Adviser represents and
warrants to the Initial Purchaser as follows: 

 

(a)             The Adviser is a limited liability company duly formed and validly existing in good standing under the laws of the State
of Delaware, with full limited liability company power and authority to own, lease and operate its properties and assets and to
conduct its business as described in the Disclosure Package and the Final Offering Memorandum, and is duly qualified to do business
as a foreign limited liability company and is in good standing under the laws of each jurisdiction which requires such qualification,
except where the failure to be so qualified and in good standing would not, individually or in the aggregate, have a material adverse
effect on (i) the performance of this Agreement or the consummation of any of the transactions herein contemplated or (ii) the
condition (financial or otherwise), earnings, or business or properties of the Adviser, whether or not arising from transactions
in the ordinary course of business (clauses (i) and (ii) together or individually with respect to the Adviser, an “Adviser
Material Adverse Effect”).

 

    9

    

    

 

(b)             The Adviser is duly registered with the Commission as an investment adviser under the Advisers Act and is not prohibited
by the Advisers Act or the 1940 Act from acting under the Advisory Agreement as investment adviser to the Company as contemplated
by the Disclosure Package and the Final Offering Memorandum. There does not exist any proceeding or, to the Adviser’s knowledge,
any facts or circumstances the existence of which could lead to any proceeding which might adversely affect the registration of
the Adviser with the Commission.

 

(c)             The Adviser has full limited liability company power and authority to enter into this Agreement and the Advisory Agreement;
the execution and delivery of this Agreement and the Advisory Agreement to the Adviser, and the performance by the Adviser of its
obligations under this Agreement and the Advisory Agreement, have been duly and validly authorized by the Adviser; and this Agreement
and the Advisory Agreement to the Adviser have been duly executed and delivered by the Adviser and, assuming due execution and
delivery hereof by you, constitute the valid and legally binding agreements of the Adviser, enforceable against the Adviser in
accordance with their terms, except as rights to indemnity and contribution hereunder may be limited by federal or state securities
laws or principles of public policy and subject to the qualification that the enforceability of the Adviser’s obligations
hereunder and thereunder may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium and other
laws relating to or affecting creditors’ rights generally and by general equitable principles, regardless whether enforcement
is considered in a proceeding in equity or at law.

 

(d)             The Adviser has the financial resources and appropriately skilled personnel available to it necessary for the performance
of its services and obligations as described in the Disclosure Package and the Final Offering Memorandum and as contemplated under
this Agreement and the Advisory Agreement.

 

(e)             The description of the Adviser and its business, and the statements attributable to the Adviser in the Disclosure Package
and the Final Offering Memorandum complied and comply in all material respects with the provisions of the Advisers Act and the
1940 Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in
order to make the statements therein, in light of the circumstances under which they were made, not misleading. The Adviser is
not aware that any executive, key employee or significant group of employees of the Adviser plans to terminate employment with
the Company or the Adviser.

 

(f)              No action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Adviser or its property is pending or, to the best knowledge of the Adviser, threatened that would reasonably be expected to
have an Adviser Material Adverse Effect.

 

(g)             The Adviser has such licenses, permits and authorizations of governmental or regulatory authorities as are necessary to
own its property and to conduct its business in the manner described in the Disclosure Package and the Final Offering Memorandum,
except where the failure to obtain such licenses, permits or authorizations would not have an Adviser Material Adverse Effect.
The Adviser has fulfilled and performed all its material obligations with respect to such licenses, permits or authorizations and
no event has occurred which allows, or after notice or lapse of time would allow, revocation or termination thereof or results
in any other material impairment of the rights of the Adviser under any such licenses, permits or authorizations.

 

    10

    

    

 

(h)             Neither the execution, delivery or performance of this Agreement by the Adviser or of the Advisory Agreement nor the consummation
by the Adviser of the transactions herein contemplated or by the Adviser of the transactions therein contemplated: (i) conflicts
or will conflict with or constitutes or will constitute a breach of the certificate of formation or limited liability company operating
agreement of the Adviser; (ii) conflicts or will conflict with or constitutes or will constitute a breach of or a default under,
any material agreement, indenture, lease or other instrument to which the Adviser is a party or by which it or any of its properties
may be bound, except for such conflicts that would not result in an Adviser Material Adverse Effect; or (iii) violates or will
violate any material statute, law, regulation or filing or judgment, injunction, order or decree applicable to the Adviser or any
of its properties or, other than pursuant to the terms of Section 5(h) hereof, will result in the creation or imposition of
any material lien, charge or encumbrance upon any property or assets of the Adviser pursuant to the terms of any agreement or instrument
to which the Adviser is a party or by which the Adviser may be bound or to which any of the property or assets of the Adviser is
subject, except to the extent for such violations, liens, charges or encumbrances that would not result in an Adviser Material
Adverse Effect, it being understood and agreed that for purposes of this representation and warranty, the transactions contemplated
under the Advisory Agreement do not include any prospective investment transactions generally authorized therein.

 

(i)              The Adviser has not taken, directly or indirectly, any action designed to or that would constitute or that might reasonably
be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Securities, and the Adviser is not aware of any such action taken or to
be taken by any affiliates of the Adviser.

 

(j)              The Adviser is not aware that (i) any of the Adviser’s executives, key employees or significant group of employees
plans to terminate employment with the Adviser or (ii) any such executive or key employee is subject to any noncompete, nondisclosure,
confidentiality, employment, consulting or similar agreement that would be violated by the present or proposed business activities
of the Company or the Adviser except where such termination or violation would not constitute an Adviser Material Adverse Effect.

 

Any certificate signed
by any officer of the Adviser and delivered to the Initial Purchaser or its counsel in connection with the offering of the Securities
shall be deemed a representation and warranty by the Adviser, as to matters covered therein, to the Initial Purchaser.

 

3.           
Purchase and Sale. Subject to the terms and conditions and in reliance upon
the representations and warranties herein set forth, the Company agrees to sell to the Initial Purchaser, and the Initial Purchaser
agrees to purchase from the Company, the aggregate principal amount of Securities set forth opposite its name on Schedule I
attached hereto. The purchase price for the Securities shall be 98.8% of the portion of the aggregate principal amount up to and
including $100 million and 99.0% of the portion of the aggregate principal amount over $100 million.

 

4.           
Delivery and Payment. Delivery of and payment for the Securities shall be
made at 10:00 AM, New York City time, on December 5, 2019, or at such time on such later date not more than two Business Days (as
defined below) after the foregoing date as the Initial Purchaser shall designate (such date and time of delivery and payment for
the Securities being herein called the “Closing Date”). Delivery of
the Securities shall be made to the Initial Purchaser against payment by the Initial Purchaser of the purchase price thereof to
or upon the order of the Company by wire transfer payable in same-day funds to an account specified by the Company. Delivery of
the Securities shall be made through the facilities of The Depository Trust Company (“DTC”)
unless the Initial Purchaser shall otherwise instruct the Company in writing. “Business Day” shall mean any day other
than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorized or obligated
by law to close in New York City.

 

    11

    

    

 

5.           
Agreements of the Company and the Adviser. The Company and the Adviser,
jointly and severally, agree with the Initial Purchaser as follows: 

 

(a)              To furnish the Initial Purchaser and those persons identified by the Initial Purchaser, without charge, as many copies of
the Preliminary Offering Memorandum, the Pricing Term Sheet, any Issuer Written Communication and the Final Offering Memorandum,
and any amendments or supplements thereto, as the Initial Purchaser may reasonably request. The Company consents to the use of
the Preliminary Offering Memorandum, the Pricing Term Sheet (as defined below) and the Final Offering Memorandum, and any amendments
or supplements thereto, by the Initial Purchaser in connection with resales to Subsequent Purchasers.

 

(b)             As promptly as practicable following the execution and delivery of this Agreement and in any event not later than the second
business day following the date hereof, to prepare and deliver to the Initial Purchaser the Final Offering Memorandum, which shall
consist of the Preliminary Offering Memorandum as modified only by the information contained in the Pricing Term Sheet, not to
amend or supplement the Preliminary Offering Memorandum or the Pricing Term Sheet, not to amend or supplement the Final Offering
Memorandum prior to the Closing Date, unless the Initial Purchaser shall previously have been advised of such proposed amendment
or supplement at least two business days prior to the proposed use, and shall not have objected to such amendment or supplement.

 

(c)             The
Company will immediately notify the Initial Purchaser, and confirm such notice in writing of (i) any filing made by the Company
of information relating to the offering of the Securities with any securities exchange or any other regulatory body in the United
States or any other jurisdiction, and (ii) prior to the earlier of the completion of the placement of the Securities by the Initial
Purchaser or nine months following the Closing Date, any Material Adverse Effect or Adviser Material Adverse Effect which (A)
makes any statement in the Disclosure Package or any Offering Memorandum in light of the circumstances under which they were made,
false or misleading or (B) is not disclosed in the Disclosure Package or the Final Offering Memorandum. In such event and during
such time any event shall occur as a result of which it is necessary, in the reasonable opinion of any of the Company, its counsel,
the Initial Purchaser or its counsel, to amend or supplement the Disclosure Package or any Offering Memorandum in order that the
same not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein not misleading in the light of the circumstances then existing, the Company, subject to Section 5(d), will forthwith
amend or supplement the Disclosure Package or such Offering Memorandum, as the case may be, by preparing and furnishing to the
Initial Purchaser an amendment or amendments or supplement or supplements thereto (in form and substance reasonably satisfactory
in the opinion of counsel for the Initial Purchaser) so that, as so amended or supplemented, the Disclosure Package or such Offering
Memorandum, as the case may be, does not include an untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances existing at the time it is delivered to a Subsequent
Purchaser, not misleading.

 

(d)             Prior to the earlier of the time of completion of the placement of the Securities by the Initial Purchaser to Subsequent
Purchasers or nine months following the Closing Date, the Company will give the Initial Purchaser notice of its intention to prepare
any supplement or amendment to the Offering Memorandum, will furnish the Initial Purchaser with copies of any such amendment or
supplement a reasonable amount of time as practicable prior to such proposed use, and will not use any such amendment or supplement
to which the Initial Purchaser or its counsel shall reasonably object. Neither the consent of the Initial Purchaser, nor its delivery
of any such amendment or supplement, shall constitute a waiver of any of the conditions set forth in Section 6 hereof. The
Company will prepare a Pricing Term Sheet, in the form attached hereto as Exhibit A (the “Pricing Term
Sheet”) and shall deliver it to the Initial Purchaser prior to the Time of Sale.

 

    12

    

    

 

(e)             Prior to the earlier of the time of completion of the placement of the Securities by the Initial Purchaser to Subsequent
Purchasers or nine months following the Closing Date, if any event occurs as a result of which, in the reasonable judgment of the
Company, the Final Offering Memorandum as then supplemented would include any untrue statement of a material fact or omit to state
any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading,
the Company promptly will: (i) notify the Initial Purchaser of any such event; (ii) prepare an amendment or supplement which will
correct such statement or omission or effect such compliance; and (iii) supply any supplemented Offering Memorandum to the Initial
Purchaser in such quantities as the Initial Purchaser may reasonably request.

 

(f)              Prior to the earlier of the time of completion of the placement of the Securities by the Initial Purchaser to Subsequent
Purchasers or nine months following the Closing Date, if there occurs an event or development as a result of which the Disclosure
Package would include an untrue statement of a material fact or would omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances then prevailing, not misleading, the Company will notify promptly the
Initial Purchaser so that any use of the Disclosure Package may cease until it is amended or supplemented.

 

(g)             The Company will cooperate with the Initial Purchaser and use its reasonable best efforts to permit the Securities to be
eligible for clearance and settlement through the facilities of DTC.

 

(h)             The Company will arrange, if necessary, for the qualification of the Securities for sale under the laws of such jurisdictions
as the Initial Purchaser may designate and will maintain such qualifications in effect so long as required for the distribution
of the Securities; provided that in no event shall the Company be obligated to qualify to do business in any jurisdiction
where it is not now so qualified or to take any action that would subject it to service of process in suits, other than those arising
out of the offering or sale of the Securities, in any jurisdiction where it is not now so subject. Until the offering of the Securities
is complete, the Company will file all documents required to be filed with the Commission pursuant to the 1940 Act and Exchange
Act within the time periods required thereby.

 

(i)              The Company and the Adviser will not, without the prior written consent of the Initial Purchaser, offer, sell, contract
to sell, pledge, or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to,
result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise)
by the Company or the Adviser or any Affiliate of the Company or any person in privity with the Company or any Affiliate of the
Company, directly or indirectly, including the filing (or participation in the filing) of a registration statement with the Commission
in respect of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the
meaning of Section 16 of the Exchange Act) any senior notes or any securities convertible into, or exercisable, or exchangeable
for, senior notes other than the Securities; or publicly announce an intention to effect any such transaction for a period beginning
on the date hereof and extending through the Closing Date.

 

    13

    

    

 

(j)              The Company and the Adviser will not take, directly or indirectly, any action designed to or that would constitute or that
might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price
of any security of the Company to facilitate the sale or resale of the Securities.

 

(k)             The Company will comply with all applicable securities and other applicable laws, rules and regulations, including, without
limitation, the Sarbanes-Oxley Act, and will use its best efforts to cause the Company’s directors and officers, in their
capacities as such, to comply with such laws, rules and regulations, including, without limitation, the provisions of the Sarbanes-Oxley
Act.

 

(l)              The
Company agrees to apply the net proceeds from the sale of the Securities in the manner set forth under the caption “Use
of Proceeds” in the Disclosure Package and the Final Offering Memorandum.

 

(m)            The Company agrees to pay the costs and expenses relating to the following matters: (i) the preparation, printing or reproduction
of the Preliminary Offering Memorandum and the Final Offering Memorandum, any Issuer Written Communication and each amendment or
supplement to any of them; (ii) the printing (or reproduction) and delivery (including postage, air freight charges and charges
for counting and packaging) of such copies of the Preliminary Offering Memorandum, Issuer Written Communication and the Final Offering
Memorandum and all amendments or supplements to any of them, as may, in each case, be reasonably requested for use in connection
with the offering and sale of the Securities; (iii) the preparation, printing, authentication, issuance and delivery of certificates
for the Securities, including any stamp or transfer taxes in connection with the original issuance and sale of the Securities to
the Initial Purchaser; (iv) the printing (or reproduction) and delivery of this Agreement, any blue sky memorandum, dealer agreements
and all other agreements or documents printed (or reproduced) and delivered in connection with the offering of the Securities;
(v) any expenses and fees for the cost of ratings agencies; (vi) any registration or qualification of the Securities for offer
and sale under the securities or blue sky laws of the several states (including filing fees and the reasonable and documented fees
and expenses of counsel for the Initial Purchaser relating to such registration and qualification and the preparation of the blue
sky memorandum, subject to the aggregate cap set forth in Section 5(m)(xi) below); (vii) any filings required to be made with FINRA
(including filing fees and the reasonable fees and expenses of counsel for the Initial Purchaser relating to such filings, subject
to the aggregate cap set forth in Section 5(m)(xi) below); (viii) the transportation and other expenses of the Company’s
officers in connection with presentations to prospective purchasers of the Securities; (ix) the fees and expenses of the Company’s
accountants and the fees and expenses of counsel (including local and special counsel) for the Company; (x) the costs and expenses
of causing the Securities to continue to be eligible for clearance through DTC; (xi) reimbursement of the Initial Purchaser’s
actual out-of-pocket expenses incurred in connection with its services (including the reasonable and documented fees and disbursements
of its legal counsel), which aggregate amount of legal fees shall not exceed $75,000 and which aggregate amount of other expenses
not related to legal fees shall not exceed $10,000; and (xii) all other costs and expenses incident to the performance by the Company
of its obligations hereunder.

 

(n)             The Adviser will direct the investment of the net proceeds of the offering of the Securities in such a manner as to comply
with the investment objectives, policies and restrictions of the Company as described in the Disclosure Package and the Final Offering
Memorandum.

 

    14

    

    

 

(o)             The Company will advise the Initial Purchaser promptly, confirming such advice in writing, of the receipt of any notification
with respect to the modification, rescission, withdrawal or suspension of the qualification of the Securities, or of any exemption
from such qualification or from registration of the Securities, for offering or sale in any jurisdiction, or of the initiation
or threatening of any proceedings for any of such purposes, including notices of any action or investigation by the Commission
regarding the Company, and, if any government agency or authority should issue any such order, to make every reasonable effort
to obtain the lifting or removal of such order as soon as possible.

 

(p)             The Company shall use its commercially reasonable efforts to maintain its qualification to be treated as a RIC under Subchapter
M of the Code, for each full fiscal year during which it is a business development company under the 1940 Act.

 

(q)             The Company and the Adviser will use their reasonable best efforts to perform all of the agreements required of them by
this Agreement and discharge all their conditions to closing as set forth in this Agreement.

 

(r)              The Company shall cause the Securities, prior to the Closing Date, to be assigned the rating set forth in the Pricing Term
Sheet attached hereto as Exhibit A.

 

6.            
Conditions to the Obligation of the Initial Purchaser. The obligation of
the Initial Purchaser to purchase the Securities shall be subject to the accuracy of the representations and warranties on the
part of the Company and the Adviser contained herein as of the date and time that this Agreement is executed and delivered by the
parties hereto (the “Execution Time”), the Time of Sale and the Closing
Date, to the accuracy of the statements of the Company or the Adviser made in any certificates pursuant to the provisions hereof,
to the performance by the Company or the Adviser of its obligations hereunder and to the following additional conditions (except
to the extent that any such conditions may have been waived in writing by the Initial Purchaser on or prior to such respective
dates): 

 

(a)              The Company shall have requested and caused Dechert LLP and Venable LLP, counsel for the Company, to have furnished to the
Initial Purchaser their respective opinions, dated the Closing Date and addressed to the Initial Purchaser, each in the form and
substance to be agreed by the parties.

 

(b)             The Initial Purchaser shall have received on the Closing Date the favorable opinion of Nelson Mullins Riley & Scarborough
LLP, counsel for the Initial Purchaser, dated the Closing Date and addressed to the Initial Purchaser.

 

(c)             Each of the Company and the Adviser shall have furnished to the Initial Purchaser certificates, signed by the Chief Executive
Officer and the principal financial or accounting officer of the Company and by the manager of the Adviser, each dated the Closing
Date, to the effect that the signers of such certificates have carefully examined the Disclosure Package, the Final Offering Memorandum,
any supplements or amendments to the Final Offering Memorandum and this Agreement and that:

 

(i)           
The representations and warranties of the Company and the Adviser in this Agreement are true and correct as of the date
hereof, as of the Time of Sale and on and as of the Closing Date with the same effect as if made on the Closing Date and the Company
and the Adviser have complied with all the agreements and satisfied all the conditions on its part that are respectively required
to be performed or satisfied by them at or prior to the Closing Date; and

 

    15

    

    

 

(ii)          
Since the date of the most recent financial statements included or incorporated in the Disclosure Package and the Final
Offering Memorandum (with respect to the certificate of the Company) and since the dates of the Disclosure Package and the Final
Offering Memorandum (with respect to the certificate of the Adviser), there has been no Material Adverse Effect or Adviser Material
Adverse Effect.

 

(d)             The Company shall have requested and caused Ernst & Young LLP to have furnished to the Initial Purchaser, at the Execution
Time and at the Closing Date, letters, dated respectively as of the Execution Time and as of the Closing Date, in form and substance
heretofore approved by the Initial Purchaser.

 

(e)             Subsequent to the Execution Time or, if earlier, the dates as of which information is given in the Disclosure Package (exclusive
of any supplement thereto) and the Final Offering Memorandum (exclusive of any supplement thereto), there shall not have been (i)
any material change specified in the letter or letters referred to in paragraph (d) of this Section 6 delivered on the Closing
Date from the letter delivered at the Execution Time or (ii) any change in the condition (financial or otherwise), earnings, business
or properties of the Company and its Subsidiaries, considered as one enterprise, and the Adviser, whether or not arising from transactions
in the ordinary course of business except as set forth in or contemplated in the Disclosure Package and the Final Offering Memorandum
(exclusive of any supplement thereto), the effect of which, in any case referred to in clause (i) or (ii) above, is, in the sole
judgment of the Initial Purchaser, so material and adverse as to make it impractical or inadvisable to proceed with the offering
or delivery of the Securities as contemplated by the Disclosure Package and the Final Offering Memorandum (exclusive of any supplement
thereto).

 

(f)              The Company and the Trustee shall have executed and delivered the Indenture in form and substance satisfactory to the Initial
Purchaser and the Initial Purchaser shall have received copies thereof.

 

(g)             Prior to the Closing Date, the Company and the Adviser shall have furnished to the Initial Purchaser such further information,
certificates and documents as the Initial Purchaser may reasonably request.

 

(h)             Subsequent to the Execution Time, there shall not have been any decrease in the rating of any of the Company’s debt
securities by any “nationally recognized statistical rating organization” (as defined in Section 3(a)(62) of the
Exchange Act) or any notice given of any intended or potential decrease in any such rating or of a possible change in any such
rating that does not indicate the direction of the possible change.

 

(i)              All agreements set forth in the DTC Agreement relating to the approval of the Securities by DTC for “book-entry”
transfer shall have been complied with.

 

If any of the conditions
specified in this Section 6 shall not have been fulfilled when and as provided for in this Agreement, or if any of the opinions
and certificates mentioned above or elsewhere in this Agreement shall not be reasonably satisfactory in form and substance to the
Initial Purchaser and its counsel, this Agreement and all obligations of the Initial Purchaser hereunder may be canceled at, or
at any time prior to, the Closing Date by the Initial Purchaser (unless any such conditions have been waived in writing by the
Initial Purchaser on or prior to such respective dates). Notice of such cancellation shall be given to the Company in writing or
by telephone or facsimile confirmed in writing.

 

    16

    

    

 

 

The documents required
to be delivered by this Section 6 shall be delivered at the office of Nelson Mullins Riley & Scarborough LLP, counsel
for the Initial Purchaser, at 101 Constitution Avenue, NW, Suite 900, Washington, DC 20001, Attention: Jonathan H. Talcott,
on the Closing Date.

 

7.            Subsequent
Offers and Resales of the Securities.

 

(a)              The
Initial Purchaser and the Company, as applicable, hereby establishes, represents and warrants and agrees to observe the following
procedures in connection with the offer and sale of the Securities:

 

(i)                 Offers,
including the distribution of any documents listed on Schedule IV, and sales of the Securities shall only be made to persons
whom the offeror or seller reasonably believes to be qualified institutional buyers, as defined in Rule 144A under the 1933 Act
(“Qualified Institutional Buyers”) or institutional accredited investors under Rule 501(a)(1), (2),
(3) or (7) under the 1933 Act.

 

(ii)                Other
than those items listed on Schedule III hereto, no general solicitation or general advertising (within the meaning of Rule
502(c) under the 1933 Act or any manner involving a public offering within the meaning of Section 4(a)(2) of the 1933 Act)
has been or will be used in the United States in connection with the offering or sale of the Securities.

 

(iii)               Prior
to or contemporaneously with the purchase of any Securities, the Initial Purchaser will inform persons acquiring Securities from
the Initial Purchaser that the Securities (A) have not been and will not be registered under the 1933 Act, (B) are being sold
to them without registration under the 1933 Act in reliance on Rule 144A and (C) may not be offered, sold or otherwise transferred
except (1) to the Company or any of its subsidiaries, (2) as long as the Securities are eligible for resale pursuant to Rule 144A,
to a person whom the seller reasonably believes is a Qualified Institutional Buyer that is purchasing such Securities for its
own account or for the account of a Qualified Institutional Buyer to whom notice is given that the offer, sale or transfer is
being made in reliance on Rule 144A, (3) to an institutional accredited investor (within the meaning of Rule 501(a)(1), (2), (3)
or (7) under the 1933 Act) that is purchasing for its own account or for the account of another institutional accredited investor
or (4) pursuant to any other available exemption from the registration requirements of the 1933 Act.

 

(iv)               The
notice to investors and the other provisions set forth in the Offering Memorandum under the heading “Notice to Investors,”
including the legend required thereby, shall apply to the Securities, except as otherwise agreed by the Company and the Initial
Purchaser. Following the sale of the Securities by the Initial Purchaser to Subsequent Purchasers pursuant to the terms hereof,
the Initial Purchaser shall not be liable or responsible to the Company for any losses, damages or liabilities suffered or incurred
by the Company, including any losses, damages or liabilities under the 1933 Act, arising from or relating to any resale, transfer
or exchange of any Security by any Subsequent Purchaser.

 

(b)             Covenants
of the Company. The Company covenants with the Initial Purchaser as follows:

 

(i)                 The
Company agrees that it will not, and will cause its Affiliates not to, directly or indirectly, solicit any offer to buy, sell
or make any offer or sale of, or otherwise negotiate in respect of, securities of the Company of any class if, as a result of
the doctrine of “integration” referred to in Rule 502 under the 1933 Act, such offer or sale would render invalid
(for the purpose of: (A) the offer and, if applicable, sale of the Securities by the Company to the Initial Purchaser, (B) the
reoffer and, if applicable, resale of the Securities by the Initial Purchaser to Subsequent Purchasers or (C) the reoffer and,
if applicable, resale of the Securities by such Subsequent Purchasers to others) the exemption from the registration requirements
of the 1933 Act provided by Section 4(a)(2) thereof or by Rule 144A thereunder or otherwise.

 

    17

     

    

 

(ii)                The
Company agrees that, in order to render the Securities eligible for resale pursuant to Rule 144A under the 1933 Act, while any
of the Securities remain outstanding and during any period in which the Company is not subject to Section 13 or 15(d) of
the Exchange Act, it will make available, upon request, to any holder or beneficial owner of Securities or prospective purchasers
of Securities the information specified in Rule 144A(d)(4). In addition, to the extent the Company is subject to Section 13
or 15(d) of the Exchange Act, the Company shall timely file all reports under the Exchange Act.

 

(iii)               Until
the expiration of one year after the original issuance of the Securities, the Company will not, and will cause its Affiliates
not to, resell any of the Securities which are “restricted securities” (as such term is defined under Rule 144(a)(3)
under the 1933 Act), whether as beneficial owner or otherwise (except as agent acting as a securities broker on behalf of and
for the account of customers in the ordinary course of business in unsolicited brokers’ transactions).

 

(c)             Qualified
Institutional Buyer. The Initial Purchaser represents and warrants to, and agrees with, the Company that it is a Qualified
Institutional Buyer and an “accredited investor” within the meaning of Rule 501(a) under the 1933 Act.

 

8.            Reimbursement
of Initial Purchaser’s Expenses. Notwithstanding Section 5(m), if the sale of the
Securities provided for herein is not consummated (i) because any condition to the obligations of the Initial Purchaser set forth
in Section 6 hereof is not satisfied, (ii) because of any termination of this Agreement pursuant to Section 10(a) hereof,
or (iii) because of any refusal, inability or failure on the part of the Company or the Adviser to perform any agreement herein
or comply with any provision hereof, the Company will reimburse the Initial Purchaser on demand for all out-of-pocket expenses
(including reasonable and documented fees and disbursements of counsel) that shall have been incurred by it in connection with
the proposed purchase and sale of the Securities. 

 

9.            Indemnification
and Contribution.

 

(a)             The
Company and the Adviser, jointly and severally, agree to indemnify and hold harmless the Initial Purchaser, the directors, officers,
employees and agents of the Initial Purchaser and each person who controls the Initial Purchaser within the meaning of either
the 1933 Act or the Exchange Act against any and all losses, claims, damages or liabilities, joint or several (including reasonable
and documented costs of investigation), to which they or any of them may become subject under the 1933 Act, the Exchange Act or
other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material
fact contained in any Preliminary Offering Memorandum, the Disclosure Package, any Issuer Written Communication (including, but
not limited to, any electronic road show or the Final Offering Memorandum (or any amendment or supplement to any of the foregoing)),
or (ii) the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were made, not misleading, and subject to the provisions
hereof, agrees to reimburse each such indemnified party, as incurred, for any documented legal or other expenses reasonably incurred
by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however,
that the Company and the Adviser will not be liable in any such case to the extent that any such loss, claim, damage or liability
arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein
in reliance upon and in conformity with written information furnished to the Company and the Adviser by the Initial Purchaser
specifically for inclusion therein, it being understood that the only information furnished by the Initial Purchaser consists
of the information described as such in the last sentence of Section 9(b). This indemnity agreement will be in addition to
any liability which the Company and the Adviser may otherwise have to the indemnified parties.

 

    18

     

    

 

(b)             The
Initial Purchaser agrees to indemnify and hold harmless each of the Company and the Adviser, the directors, employees, as applicable,
officers and agents of the Company and the Adviser and each person who controls the Company or the Adviser within the meaning
of either the 1933 Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company and the Adviser to
the Initial Purchaser, but only with reference to written information relating to the Initial Purchaser furnished to the Company
or the Adviser by the Initial Purchaser specifically for inclusion in the documents referred to in the foregoing indemnity. This
indemnity agreement will be in addition to any liability which the Initial Purchaser may otherwise have to the Company and the
Adviser. The Company and the Adviser acknowledge that the statements set forth in the second sentence of the third paragraph and
the first five sentences of the twelfth paragraph of the section titled “Plan of Distribution” in any Preliminary
Offering Memorandum and the Final Offering Memorandum constitute the only information furnished in writing by the Initial Purchaser
for inclusion in any Preliminary Offering Memorandum or the Final Offering Memorandum.

 

(c)             Promptly
after receipt by an indemnified party under this Section 9 of notice of the commencement of any action, such indemnified
party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 9, notify the indemnifying
party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i) will not relieve the indemnifying
party from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such
failure results in the forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not, in any event,
relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided
in paragraph (a) or (b) above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice
at the indemnifying party’s expense to represent the indemnified party in any action for which indemnification is sought
(in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained
by the indemnified party or parties except as set forth below) and to control such action; provided, however, that such
counsel shall be satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to appoint counsel
to represent the indemnified party in an action, the indemnified party shall have the right to employ separate counsel (including
local counsel), and the indemnifying party shall bear the reasonable and documented fees, costs and expenses of such separate
counsel if (A) the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel
with a conflict of interest, (B) the actual or potential defendants in, or targets of, any such action include both the indemnified
party and the indemnifying party and the indemnified party shall have reasonably concluded that there may be legal defenses available
to it and/or other indemnified parties which are different from or additional to those available to the indemnifying party, (C)
the indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified
party within a reasonable time after notice of the institution of such action or (D) the indemnifying party shall authorize the
indemnified party to employ separate counsel at the expense of the indemnifying party.

 

    19

     

    

 

(d)             In
the event that the indemnity provided in paragraph (a) or (b) of this Section 9 is unavailable to or insufficient to hold
harmless an indemnified party for any reason, the Company, the Adviser and the Initial Purchaser severally agree to contribute
to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection
with investigating or defending same) (collectively “Losses”) to which the Company, the Adviser and
the Initial Purchaser may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company
and the Adviser, on the one hand (treated jointly for this purpose as one person), and by the Initial Purchaser, on the other,
from the offering of the Securities; provided, however, that in no case shall the Initial Purchaser be responsible for
any amount in excess of the Initial Purchaser’s discount or commission applicable to the Securities purchased by the Initial
Purchaser hereunder. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company,
the Adviser and the Initial Purchaser shall contribute in such proportion as is appropriate to reflect not only such relative
benefits but also the relative fault of the Company and the Adviser, on the one hand (treated jointly for this purpose as one
person), and of the Initial Purchaser, on the other, in connection with the statements or omissions which resulted in such Losses
as well as any other relevant equitable considerations. Benefits received by the Company, and the Adviser (treated jointly for
this purpose as one person) shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses)
received by it, and benefits received by the Initial Purchaser shall be deemed to be equal to the total Initial Purchaser’s
discounts and commissions, in each case as set forth on the cover page of the Final Offering Memorandum. Relative fault of the
parties shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to information provided by the Company and the Adviser,
on the one hand (treated jointly for this purpose as one person), or the Initial Purchaser, on the other, the intent of the parties
and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The
Company, the Adviser and the Initial Purchaser agree that it would not be just and equitable if contribution pursuant to this
Section 9 were determined by pro rata allocation or any other method of allocation which does not take account of the equitable
considerations referred to above. Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. For purposes of this Section 9, each person who controls the Initial Purchaser within
the meaning of either the 1933 Act or the Exchange Act and each director, officer, employee and agent of the Initial Purchaser
shall have the same rights to contribution as the Initial Purchaser, and each person who controls the Company or the Adviser within
the meaning of either the 1933 Act or the Exchange Act, and each director, officer and agent of the Company and the Adviser shall
have the same rights to contribution as the Company and the Adviser, subject in each case to the applicable terms and conditions
of this paragraph (d).

 

(e)             No
indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or
threatened action, suit or proceeding in respect of which any indemnified party is or could have been a party and indemnity could
have been sought hereunder by such indemnified party, unless such settlement (i) includes an unconditional release of such indemnified
party from all liability from claimants on claims that are the subject matter of such action, suit or proceeding and (ii) does
not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.
Subject to the following sentence, an indemnifying party shall not be liable to an indemnified party under this Section 9
for any settlement of any claim or action effected without the prior written consent of such indemnifying party, which shall not
be unreasonably withheld. If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified
party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature
contemplated by this Section 9 effected without its written consent if (A) such settlement is entered into more than 45 days
after receipt by such indemnifying party of the aforesaid request, (B) such indemnifying party shall have received notice of the
terms of such settlement at least 30 days prior to such settlement being entered into and (C) such indemnifying party shall not
have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.

 

    20

     

    

 

(f)              Any
losses, claims, damages, liabilities or expenses for which an indemnified party is entitled to indemnification or contribution
under this Section 9 shall be paid by the indemnifying party to the indemnified party as such losses, claims, damages, liabilities
or expenses are incurred. The indemnity and contribution agreements contained in this Section 9 and the representations and
warranties of the Company and the Adviser set forth in this Agreement shall remain operative and in full force and effect, regardless
of (i) any investigation made by or on behalf of the Initial Purchaser or any person controlling the Initial Purchaser, the Company,
the Adviser or their shareholders, trustees, directors, managers, members or officers or any person controlling the Company or
the Adviser (control to be determined within the meaning of the 1933 Act or the Exchange Act), (ii) acceptance of any Securities
and payment therefor hereunder and (iii) any termination or cancellation of this Agreement. A successor to the Initial Purchaser
or to the Company, the Adviser or their shareholders, trustees, directors, managers, members or officers or any person controlling
the Initial Purchaser, the Company or the Adviser shall be entitled to the benefits of the indemnity, contribution and reimbursement
agreements contained in this Section 9.

 

10.         Termination.

 

(a)             This
Agreement shall be subject to termination in the absolute discretion of the Initial Purchaser, without liability on the part of
the Initial Purchaser to the Company or the Adviser, by notice given to the Company, or the Adviser prior to delivery of and payment
for the Securities, if at any time prior to such time: (i) there has been, since the Execution Time, or since the respective dates
as of which information is given in the Disclosure Package and the Final Offering Memorandum, any material adverse change in the
condition (financial or otherwise), earnings, business or properties of the Company and its Subsidiaries, considered as a single
enterprise, or the Adviser, whether or not arising in the ordinary course of business, which would, in the sole judgment of the
Initial Purchaser, make it impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated
by the Preliminary Offering Memorandum or the Final Offering Memorandum (exclusive of any supplement thereto); (ii) trading
in securities generally on the New York Stock Exchange, Inc. (the “NYSE”) shall have been suspended
or limited or minimum prices shall have been established on the NYSE; (iii) a banking moratorium shall have been declared either
by federal or New York State authorities; (iv) a material disruption has occurred in securities settlement or securities
clearance in the United States; or (v) there shall have occurred any outbreak or escalation of hostilities, declaration by
the United States of a national emergency or war, or other calamity or crisis the effect of which on financial markets is such
as to make it, in the sole judgment of the Initial Purchaser, impractical or inadvisable to proceed with the offering or delivery
of the Securities as contemplated by the Preliminary Offering Memorandum or the Final Offering Memorandum (exclusive of any supplement
thereto).

 

    21

     

    

 

(b)           Reserved.

 

11.          Representations
and Indemnities to Survive. The respective agreements, representations, warranties, indemnities
and other statements of each of the Company, and the Adviser or its officers and of the Initial Purchaser set forth in or made
pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Initial
Purchaser or the Company or the Adviser or any of the officers, trustees, directors, employees, agents or controlling persons
referred to in Section 9 hereof, and will survive delivery of and payment for the Securities. The provisions of Sections
8 and 9 hereof shall survive the termination or cancellation of this Agreement. 

 

12.          No
Fiduciary Duty. The Company hereby acknowledges and agrees that (a) the purchase and sale
of the Securities pursuant to this Agreement is an arm’s-length commercial transaction between the Company, on the one hand,
and the Initial Purchaser and any affiliate through which it may be acting, on the other, (b) the Initial Purchaser is acting
as principal and not as an agent or fiduciary of the Company and (c) the Company’s engagement of the Initial Purchaser in
connection with the offering and the process leading up to the offering is as independent contractors and not in any other capacity.
Furthermore, the Company agrees that it is solely responsible for making its own judgments in connection with the offering (irrespective
of whether the Initial Purchaser has advised or is currently advising the Company on related or other matters). The Company agrees
that it will not claim that the Initial Purchaser has rendered advisory services of any nature or respect, or owes an agency,
fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto. 

 

13.          Integration.
This Agreement supersedes all prior agreements and understandings (whether written or oral)
between the Company, the Adviser and the Initial Purchaser, or any of them, with respect to the subject matter hereof. 

 

14.          Notices.
Except as otherwise herein provided, all statements, requests, notices and agreements shall
be in writing or by telegram or facsimile and, if to the Initial Purchaser, shall be sufficient in all respects if delivered or
sent to Sandler O’Neill & Partners, L.P. on behalf of the Initial Purchaser, 1251 Avenue of the Americas, 6th
Floor, New York, New York 10020, with a copy (for informational purposes only) to Jonathan H. Talcott, Nelson Mullins Riley &
Scarborough LLP, 101 Constitution Avenue, NW, Suite 900, Washington, DC 20001; and if to the Company or Adviser, shall be sufficient
in all respects if delivered or sent to the Company at the offices of the Company at 9 West 57th Street, Suite 4920,
New York, New York 10019, Attention: Richard Byrne, with a copy to Dechert LLP, One International Place, 40th Floor,
100 Oliver Street, Boston, Massachusetts 02110, Attention: Thomas Friedmann.

 

15.          Successors. This Agreement will inure to the benefit of and be binding upon
the parties hereto and their respective successors and the officers, trustees, directors, employees, agents and controlling persons
referred to in Section 9 hereof, and no other person will have any right or obligation hereunder. 

 

16.          Applicable
Law; Waiver of Jury Trial. This Agreement will be governed by and construed in accordance
with the laws of the State of New York applicable to contracts made and to be performed within the State of New York. The parties
hereby waive any right to trial by jury in any action, proceeding or counterclaim arising out of or relating to this Agreement
or the transactions contemplated hereby.

 

17.          Counterparts.
This Agreement may be signed in one or more counterparts, each of which shall constitute an
original and all of which together shall constitute one and the same agreement.

 

18.          Headings.
The section headings used herein are for convenience only and shall not affect the construction
hereof. 

 

    22

     

    

 

If the foregoing is
in accordance with your understanding of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon this
letter and your acceptance shall represent a binding agreement among the Company, the Adviser and the Initial Purchaser.

 

	 	Very truly yours,
	 	 
	 	BUSINESS DEVELOPMENT
    CORPORATION OF AMERICA
	 	 
	 	 
	 	By: 	/s/ Nina K. Baryski
	 	 	Name:	Nina Kang Baryski
	 	 	Title:	Chief Financial Officer

 

[Signature Page to Purchase Agreement]

 

    

     

    

 

	 	BDCA ADVISER, LLC
	 	 
	 	By: BSP Acquisition I, LLC
	 	 
	 	By:	/s/
    Bryan Martoken
	 	 	Name:	Bryan Martoken
	 	 	Title:	Chief Financial Officer

 

[Signature Page to Purchase Agreement]

 

    

     

    

 

 

Accepted and
agreed to as of the date first above written:

 

	SANDLER
    O’NEILL & PARTNERS, L.P.	 
	 	 
	By:	Sandler O’Neill &
    Partners Corp.,	
	 	the
    sole general partner	 
	 	 	 
	 	 	 
	 	By:	/s/ Robert A. Kleinert	 
	 	 	Name: 	Robert A. Kleinert	 
	 	 	Title: 	An Officer of the Corporation	 

 

[Signature Page to Purchase Agreement]

 

    

     

    

 

SCHEDULE
I

 

	Initial Purchaser	 	Aggregate Principal
 Amount of
 Notes to Be Purchased
 
	 
	Sandler O’Neill & Partners, L.P.	 	$	100,000,000	 
	Total	 	$	100,000,000	 

 

    I-1

     

    

 

SCHEDULE II 

 

SUBSIDIARIES

 

	Name	 	Domicile
	BDCA Funding I, LLC	 	Delaware
	54th Street Equity Holdings, Inc.	 	Delaware
	Park Ave RE, Inc.	 	Delaware
	Kahala Aviation Holdings, LLC	 	Delaware
	Kahala Aviation US, Inc.	 	Delaware
	Kahala LuxCo	 	Luxembourg
	BDCA-CB Funding, LLC	 	Delaware
	BDCA Helvetica Funding, Ltd.	 	Cayman Islands
	BDCA 2L Funding I, LLC	 	Delaware

 

    II-1

     

    

 

SCHEDULE III

 

PERMITTED SOLICITATIONS

 

	1.	Pricing Term Sheet

 

	2.	Investor presentation, dated November 2019

 

	3.	Current Report on Form 8-K, dated December 4, 2019

 

	4.	Press Release, dated December 4, 2019

 

    III-1

     

    

 

SCHEDULE IV

 

OTHER ISSUER WRITTEN COMMUNICATIONS

 

 

	1.	The Preliminary Offering Memorandum, dated November 26,
2019

 

	2.	Investor presentation dated November 2019

 

    IV-1

     

    

 

EXHIBIT A

Pricing Term Sheet 

  

BDCA Business Development Corporation of
America

$100,000,000

4.85% Notes due 2024

 

	Issuer:	Business Development Corporation of America (“BDCA”)
	 	 
	Securities Offered:	4.85% Notes due 2024 (the “Notes”)
	 	 
	Aggregate Principal Amount:	$100,000,000
	 	 
	Expected Ratings*:	BBB by Kroll Bond Rating Agency
	 	BBB+ by Egan-Jones Ratings Company
	 	 
	Maturity Date:	December 15, 2024
	 	 
	Interest Rate:	4.85% per annum, computed on the basis of a 360-day year comprising twelve 30-day months
	 	 
	Reference Benchmark:	UST 1.50% due November 30, 2024
	 	 
	Reference Benchmark Yield:	1.54%
	 	 
	Spread to Benchmark:	331 basis points
	 	 
	Yield to Investors:	4.85%
	 	 
	Offering Price to Investors:	100%
	 	 
	Interest Payment Dates:	Interest on the Notes will be payable semi-annually in arrears on June 15 and December 15 of each year, commencing June 15, 2020.
	 	 
	Optional Redemption:	BDCA may redeem some or all of the Notes at any time, or from time to time, at a redemption price equal to the greater of (1) 100% of the principal amount of the Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable Treasury Rate plus 50 basis points, plus, in each case, accrued and unpaid interest to, but excluding, the redemption date.

 

 

    	 	A-1	 

     

    

 

	Denomination; Form:	BDCA will issue the Notes in denominations of $1,000.
	 	 
	Book Entry; Delivery	 
	and Form:	The Notes will be represented by global securities that will be deposited and registered in the name of DTC or its nominee. This means that, except in limited circumstances, you will not receive certificates for the Notes. Beneficial interests in the Notes will be represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and indirect participants in DTC. Investors may elect to hold interests in the Notes through either DTC, if they are a participant, or indirectly through organizations that are participants in DTC.
	 	 
	Ranking of Notes:	The Notes will be general unsecured obligations that:
	 	 
	 	 	·	Rank senior in right of payment to all of BDCA’s existing and future indebtedness that is expressly subordinated in right of payment to the Notes.
	 	 	·	Rank equally in right of payment with all of BDCA’s existing and future senior liabilities that are not so subordinated, effectively junior to any of BDCA’s secured indebtedness (including unsecured indebtedness that BDCA later secures) to the extent of the value of the assets securing such indebtedness, and structurally junior to all existing and future indebtedness (including trade payables) incurred by BDCA’s subsidiaries, financing vehicles or similar facilities, including BDCA’s Citibank Credit Facility and Wells Fargo Credit Facility.
	 	 	 	 
	 	As of September 30, 2019, BDCA’s total liabilities were approximately $1,235.8 million, $815.4 million of which was secured indebtedness of BDCA or its subsidiaries and $306.7 million of which was unsecured notes.
	 	 	 	 
	Covenants:	The indenture relating to the notes (the “indenture”) shall contain certain covenants, including:
	 	 	 	 
	 	 	·	The Company agrees that for the period of time during which Notes are outstanding, the Company will not violate, whether or not it is subject to, Section 18(a)(1)(A), as modified by Section 61(a)(1) of the Investment Company Act;
	 	 	·	Limits on merger, consolidation or sale of assets; and
	 	 	·	The Company will be subject to reporting requirements
	 	 	 	 
	Change of Control Triggering	 	 	 
	Event:	If a Change of Control Repurchase Event (as defined in the indenture) occurs prior to maturity, holders of the Notes will have the right, at their option, to require BDCA to repurchase for cash some or all of the Notes at a repurchase price equal to 100% of the principal amount of the Notes being repurchased, plus accrued and unpaid interest to, but excluding, the repurchase date.

 

    	 	A-2	 

     

    

 

	Manner of Sale/Transfer	 
	Restrictions:	The offering of the Notes will not be registered under the Securities Act of 1933, as amended. BDCA will sell the Notes only to “qualified institutional buyers” (as defined in Rule 144A under the Securities Act of 1933, as amended (“Securities Act”)) and institutional “accredited investors” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act). The Notes will be subject to transfer restrictions.
	 	 
	Trustee, Paying Agent, Registrar	 
	and Transfer Agent:	U.S. Bank National Association.
	 	 
	Use of Proceeds:	BDCA intends to use the net proceeds of this offering to make investments in portfolio companies in accordance with BDCA’s investment objectives, and for general corporate purposes. BDCA may use a portion of the proceeds to repay certain outstanding indebtedness.
	 	 
	No Established Trading	 
	Market:	The Notes are a new issue of securities with no established trading market. The Notes will not be listed on any securities exchange or quoted on any automated dealer quotation system. Although the initial purchasers have informed BDCA that they intend to make a market in the Notes, they are not obligated to do so, and may discontinue any such market making at any time without notice. Accordingly, BDCA cannot assure you that an active and liquid market for the Notes will develop or be maintained. BDCA is not obligated, nor does BDCA intend, to register the Notes under the Securities Act, or any state securities laws, or offer to exchange the Notes for notes registered under the Securities Act or any state securities laws. BDCA does not intend to apply for a listing of the Notes on any securities exchange or automated dealer quotation system.
	 	 
	Governing Law:	The indenture and the Notes will be governed by the laws of the State of New York.
	 	 
	CUSIP / ISIN: (144A)	12325J AF8 / US12325JAF84
	 	 
	
        CUSIP / ISIN: (Accredited Investor)
	12325J AG6 / US12325JAG67
	 	 
	Sole Book-Running Manager:	Sandler O’Neill & Partners, L.P.
	 	 
	Trade Date:	December 3, 2019
	 	 
	Settlement Date (T+2):	December 5, 2019

  

    	 	A-3	 

     

    

 

* An explanation of the significance of
ratings may be obtained from the rating agency. Generally, rating agencies base their ratings on such material and information,
and such of their own investigations, studies and assumptions, as they deem appropriate. The rating of the Notes should be evaluated
independently from similar ratings of other securities. A credit rating of a security is not a recommendation to buy, sell or hold
securities and may be subject to review, revision, suspension, reduction or withdrawal at any time by the assigning rating agency.

 

This term sheet is being provided for informational
purposes only and is not an offer to sell, or a solicitation of an offer to buy, any securities referred to herein. In the event
that an offering of securities is undertaken, any offer to sell, or solicitation of an offer to buy, shall only be made pursuant
to an offering memorandum. This document is only an indicative summary of the terms of the securities referred to herein and may
be amended, superseded or replaced by subsequent summaries and, in the event that an offering of securities is undertaken, will
be superseded by the applicable offering documents, which will set out the final terms of any securities that are offered. This
term sheet is only being provided to qualified institutional buyers and certain institutional accredited investors and is a confidential
document. Any person to whom this document is distributed must not make copies of any part hereof, give copies of any part hereof
to any other person or disclose any information contained herein to any other person. A written offering may be obtained by request
from Sandler O’Neill & Partners, L.P. at (866) 805-4128.

 

 

 

    	 	A-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]